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THE ROLE OF DOPAMINE IN MOTIVATIONAL AND RECEPTIVE ASPECTS
OF FEMALE MOUSE SEXUAL BEHAVIOR
by
Amber B. Hodges
Adviser: Victoria Luine, Ph.D.
A pacing paradigm investigated the modulatory role of monoamines in the 
mesolimbic dopamine system on copulatory behavior in female mice. Specifically 
whether there is a distinction between the neural regulatory mechanisms of pacing 
behavior and receptive behavior was determined. Pacing measures motivational and 
rewarding components of copulation by the female’s contacts and withdrawals from 
the male, while receptivity is the willingness to engage in copulations and is 
measured by the number of sexual stimulations received. A pacing paradigm was 
established and female mice were observed to pace in a similar manner, but at a lesser 
rate, than female rats.
Dopamine (DA) and its pathways regulate copulatory behaviors in female rats 
[2, 3]. General and specific DA receptor agonists were used to investigate 
dopaminergic mediation of copulatory behavior in female mice. Three doses of 
apomorphine (APO; 20pg, 60 pg and 120 pg/kg), a general dopamine agonist, [4] 
were given and resulting effects on pacing behavior, receptive behavior, and 
dopamine and metabolite levels in brain areas measured. Treatment caused dose 
dependent increases in pacing and in DA levels in the Nacc and significantly lower
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levels of HVA/D A in the striatum and Nacc. There results are consistent with 
previous studies in rats that show activation of DA terminals in there areas during 
reward. The lowest effective dose for altering pacing was 120p,g/kg. APO treatment 
was associated with dose dependent decreases in receptivity and significant increases 
of HVA in the VMN with a lowest effective dose of 60pg/kg. The VMN is the CNS 
regulatory center for receptivity. Since pacing behavior involves locomotor behavior 
and APO affects locomotion, subjects were treated with APO and locomotion, 
anxiety and exploratory behavior were measured using an open field. APO 
dependent increases in locomotion and anxiety and decreases in exploratory behavior 
may contribute to its modulation of copulatory behaviors.
In conclusion, a pacing paradigm was established for mice, and results 
showed differential effects of DA (dose and brain region) on regulation of 
motivational and rewarding vs receptive components fo female sexual behavior. This 
information can be utilized in clinical research on sexual dysfunction and drug abuse 
involving the DA mesolimbic “reward” pathway.
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I. Specific Aims
This research dissertation uses a pacing paradigm to investigate the 
modulatory role of monoamines in the mesolimbic dopamine system on copulatory 
behavior in female mice. There is particular interest in establishing a distinction 
between the neural regulatory mechanisms of pacing behavior and the neural 
regulatory mechanisms of receptive behavior. Additionally pacing behavior is being 
used to measure motivational and rewarding components of copulatory behavior. 
Dopamine (DA) and its pathways have been shown to regulate other motivational and 
rewarding behaviors [5]. Since pacing behavior in rodents is a motivational behavior 
[6], we are interested in determining if and/or how DA modulates this behavior. 
Therefore the specific aims of this research dissertation are as follows:
(1) Establishment and quantification of baseline pacing and receptive behavior in 
female mice. Pacing is a component of female rodent sexual behavior that is 
defined by the female approaching and withdrawing from the male, allowing her 
to control the frequency and amount of stimulation she receives from the male 
[7]. Pacing allows for the quantification of the motivational aspects involved in 
copulatory behavior. The pacing behavior can then be compared to receptive 
behaviors. Receptive behaviors allow the male to successfully copulate with the 
female. The lordosis posture and allowing mounts and intromissions are 
considered to be receptive behaviors (see [1, 7] fora review of rodent female sex 
behavior).
(2) Investigation of the modulatory role of neurotransmitters on both pacing and 
receptive behaviors. Of particular interest is the regulatory role of DA and its 
metabolites in the nucleus accumbens (Nacc), striatum and ventromedial nucleus
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of the hypothalamus (VMN). This aim was accomplished by quantifying pacing 
and receptive behavior and measuring levels of DA and metabolites in brain 
areas important for sexual behavior and motivation.
(3) Investigation of the role of DA receptors mediating pacing and receptive 
components of copulatory behavior. The contribution of DA receptors to the 
regulation of pacing and receptive behaviors is of particular interest. This aim 
was accomplished by administering general and specific DA receptor agonists 
and measuring pacing and receptive behavior.
Although there are new animal models available in the form of transgenic and 
knockout mice, these genetic models have not been widely used in neuroendocrine 
studies because paradigms have not been established for mice [8], Specifically, when 
examining sexual behavior, a pacing paradigm needs to be established. Once a 
pacing paradigm exists for wild type mice, it can be utilized to study the relationship 
between hormones, neurotransmitters and sexual behavior in female mice. With this 
information, we can continue to study the motivational and rewarding aspects of 
copulatory behavior in female rodents. Primarily these types of investigations have 
been confined to rats [1, 6, 7, 9], However expanding our understanding of the 
various components of copulatory behavior to mice, will allow for further 
investigation of the underlying mechanisms of how neurotransmitters and hormones 
affect sexual behavior. Knockout and transgenic mice allow researchers to examine 
and gain an improved understanding of sexual behavior, fertility, infertility and 
sexual performance problems. Understanding these effects is also important because 
it gives information on how various medical treatments alter either neurotransmitter
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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levels or hormone levels, which affect sexual behavior in animals and humans. In a 
broader sense, investigating the regulatory mechanism underlying all components of 
copulatory behavior also gives information about the sexual side effects of drugs, 
used to treat mental diseases such as depression and anxiety disorders.
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II. Overview of Sexual Receptivity in Female Rats
Studies examining rodent sexual behavior show that the females exhibit 
different degrees of receptivity in female rodents [10], The female sexual response is 
dependent on her physiological state [11]. When the female is nonreponsive to the 
male mounting attempts, she displays active resistance or rejection behavior [9]. This 
can involve rearing on her hind legs and striking the male with her forepaws [9]. If 
the male is successful in mounting, the nonreponsive female may roll on her back, 
and dislodge the male [9], She can also run away when under the male [12],
When the female is fully receptive, her behaviors are quite different. One of 
the most prominent receptive responses is the lordosis posture [13] Lordosis is a 
reflexive posture that consists of the female planting her feet firmly on the ground and 
dorsiflexion of the vertebral column, causing her rear to be lifted in the air [11].
When her rear is lifted in the air, it allows the female genital to be more accessible to 
the male [12]. If the female is very receptive, her back is fully flexed causing her 
stomach area to touch the ground [12]
Female rodent sex behavior is divided into three categories which are 
proceptive [1], motivational [1, 6, 14] and receptive behavior [1]. Proceptive 
behavior is defined as behavioral cues displayed by the female to entice the male to 
come and mate with her [1], There are two behaviors that have been observed in the 
receptive female rat, which are categorized as proceptive behaviors [1], The first is a 
hopping/darting motion, which consists of a stiff legged hop and darting motion away 
from the male. The second is ear wiggling [1]. This consists of the female rat
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
shaking her head rapidly, which causes her ears to vibrate. These behaviors signal to 
the male that the female is willing and ready to mate [1].
Motivational behavior is the female displaying behavior that shows that she is 
interested in the male mating with her and is not just displaying a reflexive response 
[6]. Pacing is categorized as a motivated behavior [6,14], because the female 
controls the frequency and amount of stimulation received from the male by using an 
escape mechanism to approach and withdraw from him.
Receptive behavior is facilitating successful mating by allowing accessibility 
of appropriate genitals. The lordosis posture is categorized as receptive behavior 
[12]. Receptivity can be measured using the lordosis quotient (number of lordosis 
postures divided by the number of mounts), lordosis quality score (quality of lordosis 
posture ranked from 0, no dorsoflexion of ventral column, to 3, dorsoflexion of 
ventral column and stomach touching the ground) [15] and number of stimulations 
(mounts, intromissions and ejaculations) received.
Lordosis
Initially, female rat sexual receptivity was quantified using a Copulatory 
quotient, a measure used to quantify the lordosis response when the female was 
mounted by the male [16]. Lordosis is a reflex behavior which is activated by the 
stimulation of the male’s mount [11] (see Fig. 1). Estrogen and progesterone enhance 
the probability that lordosis will occur following a mount [10]. Many studies have 
shown that intact female rats will display lordosis during the proestrus phase of the 
estrus cycle [7, 12] (see Fig 2.). Ovariectomized (OVX) female rats, when
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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administered estrogen and progesterone in a pattern that mimics the natural estrus 
cycle will also display high levels of lordosis responding [7,12, 16-18].
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Figure 1: Female ra t displaying lordosis posture. The Sprague Dawley (white) 
female rat is displaying the lordosis reflex when the Long Evans (black and 
white) male rat is mounting her. Her feet are planted firmly on the ground, 
dorsoflexion of verterbral column, and her head and rear are lifted in the air, 
allowing her genital to be accessible to the male [19].
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Figure 2: The days of the 4-day estrous cycle (metestrus, diestrus, proestrus, and estrus). The 
nights are represented by the dark bars on the X axis. Behavioral estrus usually begins on the night 
of proestrus. This study as well as others mimic the estrus cycle in OVX female rats by 
administering estrogen 48 and 24 hours before sexual testing and progesterone 5 hours before 
testing[l)
Additional experiments have examined the regulatory role of DA on lordosis 
behavior [20]. They found that when ovariactomized (OVX )female rats, primed with 
high doses of estrogen, are infused with DA receptor antagonists, haloperidol and a- 
flupenthixol, in the hypothalamus, lordosis behavior was significantly depressed [20], 
Subsequently, when either apomorphine (APO), a general DA agonist, or DA were 
infused in the hypothalamus, lordosis was elevated [21]. In addition, when APO was 
administered in place of progesterone, lordosis behavior was also elevated [21].
When APO was administered to OVX females, primed with estrogen and 
progesterone, lordosis behavior increased [22], There was also an increase when 
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DA agonists and antagonists for progesterone, found that APO and SKF 38393 (Di 
agonists) mimicked effects of progesterone and facilitated lordosis behavior in female 
rats. Quinpirole (D2 agonist) had no effect on lordosis [23]. Similar to female rats, 
female hamsters show high levels of lordosis when administered D2 receptor 
antagonists, sulpiride and raclopride [24]. However, place conditioning (a 
measurement of an appetitive process which signifies reward) was reduced or 
eliminated [24]. Overall, results of previous experiments show that administration of 
DA or its agonists increases receptivity in female rodents. Moreover, stimulation of 
Di receptors increases receptivity while stimulation of D2 receptors decreases 
receptivity in female rodents.
Pacing
Data from studies on receptivity of female rats, led to research examining 
solicitation behaviors that interact with male copulatory behavior [7, 25].
Solicitation behavior can include the proceptive female behaviors of ear wiggling, 
darting and hopping. These behaviors are seen in receptive females who are not 
allowed to pace [7]. There is now evidence for different neural mechanisms that 
regulate proceptive, motivational and receptive sexual behaviors [7]. For the 
purposes of this research dissertation, the neural mechanisms that modulate pacing 
behavior will be discussed. Pacing mimics more closely the natural sexual behavior 
of rodents [7]. It is observed in natural settings and large environments, and therefore 
provides an assessment of more natural female sex behavior [2], In laboratory 
experiments with rats, pacing occurs in chambers that have exit holes, which allow 
females to enter/exit the chamber of the male [7]. (see Figs. 3-4)
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Figure 3: A schematic drawing of a pacing chamber used with female rats. The pacing chamber 
consists of a testing chamber separated by a Plexiglas barrier. The Plexiglas barrier has three 
enter/exits holes which are big enough for the female (white rat) to traverse both sides of the 
chamber but not the male (black and white rat). This allows the female an escape mechanism 
which allows her to control the amount and frequency of stimulation received [26].
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Figure 4: A schematic drawing of a bilevel pacing chamber. The testing chamber is narrow, 
which maintains a male and female rat in the optimal orientation for the observer to view sexual 
behavior, i.e., in the side view. Moreover, the chamber consists of an upper and lower level, 
which allows the females an avenue of escape from the male. Females can level change, by using 
the ladders on either side of the chamber to switch levels and escape the male. The chamber is 
used to evaluate lordosis and pacing behavior[27].
m
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The sexual stimulations given by the male to the female are mounts, 
intromissions and ejaculations [1]. The male begins interacting with the female by 
smelling her anal and genital area and attempting to mount her from behind [12]. A 
mount is when the male holds the female’s hindquarters and thrusts without inserting 
his penis into the female’s vagina [12]. Mounts occur first and provide the least 
stimulation [1]. If the female is receptive, intromissions are interspersed with the 
mounts [1]. Intromissions are the insertion of penis with or without ejaculations [12]. 
Copulation ends with ejaculation by the male, which is the most intense interaction
[I]. The lordosis reflex is seen in receptive females in response to the male mount
[II]. The receptivity of the female can be measured through the lordosis quotient 
(number of lordosis / number of mounts and intromissions) [16].
Pacing behavior is used to intersperse these stimulations [1], If allowed, the 
female rodent will pace these stimulations by using an escape mechanism to approach 
and withdraw from the male [7]. This strategy allows her to control the frequency 
and amount of sexual stimulation she receives from the male [7], As the intensity of 
the stimulation increases, generally the length of the time spent away from the male 
also increases [7]. The amount of time it takes the female to return to the male is 
referred to as a return latency [7]. Pacing and return latencies are mediated by 
vaginal stimulation [7], When the vaginal area is anesthetized females do not pace, 
but they remain with the males throughout the bouts of stimulation [7]. Pacing 
behavior is seen in virgin rats as well as experienced rats, and return latencies are not 
altered by practice with or exposure to the male [7]. Also, estrogen and progesterone
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administered to OVX female rats in a pattern mimicking the natural estrus cycle, can 
induce pacing behavior at the same level of naturally cycling female rats [28]. 
Reproductive Consequences o f Pacing: Why do females pace? Why is this behavior 
interesting or relevant? Pacing behavior facilitates the likelihood of pregnancy or 
pseudopregnancy in female rats [18] [19]. Several studies have shown that fewer 
intromissions are needed to induce pregnancy or pseudopregnancy when sexual 
behavior is paced, compared to non paced sexual bouts [29]. In addition, if  a female 
receives an ejaculation during a paced mating bout, she is more likely to get pregnant 
than if the sexual bout was not paced [28], In pacing bouts, there are also longer 
inter-intromission intervals, which are more similar to natural settings, and are 
associated with a high proportion of females becoming pregnant [30]. Mating 
patterns, specifically intromissions, induce surges of serum prolactin, which persist in 
intact females for 12 days and define the period of psuedopregnancy [21]. In paced 
mating, less intromissions are needed to induce these serum prolactin surges 
compared to non-paced stimulation [29]. In addition, paced copulation increases the 
rate that estrous behavior declines toward the end of estrous[31]. Usually in female 
rats, large numbers of intromissions are needed to terminate estrus [29], However, 
when allowed to pace, the vaginal-cervical stimulation seems to have a greater effect 
on estrus termination [31]. The need for less intromissions in order to induce 
pregnancy, pseudopregnancy, and termination of the estrus cycle, during paced 
copulation is due to the female rat being able to distinguish between the intensity of 
vaginal-cervical stimulation received during each copulatory mount [28]. Thus paced
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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stimulations overall seem to have more of an effect than non-paced stimulations on 
neuroendocrine changes that are induced by mating behavior [21].
Neural Basis of Pacing Behavior: Estrogen and progesterone are well known 
endocrine regulators of pacing behavior. However the neural regulation is much less 
understood. Some studies have investigated neural sites that are sensitive to estrogen 
and progesterone and therefore considered to be involved in pacing behavior.
Previous studies examining the neural regulation of lordosis found that the VMN 
mediates lordosis so it is a likely site to begin studying pacing behavior[32-36]. 
Implanting estradiol and progesterone in the VMN has been shown to stimulate 
lordosis in OVX female rats [3 7], while lesioning the VMN, reduces lordosis behavior 
[38, 39] and the number of approaches to the male [36]. The number of approaches 
did not increase when VMN lesioned females were treated with exogenous estrogen 
and progesterone [40]. This pattern suggests that damage to the VMN disrupts the 
pattern of approach to the male and ultimately disrupts the amount of coital 
stimulation that the female receives from the male.
Other studies have focused on the efferents projecting laterally from the VMN 
to the midbrain. Lesioning parts of the midbrain that receive efferents from the VMN 
have decreased or eliminated lordosis behavior, however, proceptive and motivational 
behaviors such as hopping, darting and pacing were not affected [39]. This was seen 
in both intact and OVX females [39]. Additionally, lesions in the ventral 
noradrenergic bundle (VNAB) eliminate lordosis but not preeopulatory and pacing 
behaviors, and sometimes enhance these behaviors [40].
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Because pacing underlies the female rat’s ability to discriminate between 
different types of coital stimulation, pacing behavior may be controlled by areas in 
the brain that serve as terminals for vaginal-cervical sensory information. 
Additionally, since pacing behavior enhances the effect of mating stimulation that 
induces serum prolactin surges, the same brain areas might be involved [41], The 
preoptic area of the hypothalamus (POA) tonically inhibits the nightly surge of serum 
prolactin following cervical stimulation and, when lesioned, these surges are 
repetitive [29]. Additionally, neurons responsive to vaginal-cervical stimulation are 
located in the POA [41], But does it have a role on pacing behavior? When the POA 
was lesioned in females that are not allowed to escape from the male, lordosis was 
increased and enhanced [42], However, when POA lesioned females were allowed to 
pace, there was no increase in lordosis. Additionally, there were decreases in time 
spent with sexually active male, number of copulatory mounts received and lordosis 
poses [43].
The data supports the idea of separate of neural controls of proceptive, 
motivational and receptive components of female rodent sexual behavior. When 
some areas o f the brain VMN and VNAB are lesioned, lordosis behavior, but not 
pacing behavior is affected [39,40]. In addition, brain areas, such as the POA, that 
are important for prolactin surges of pseudopregnancy and pregnancy [44] may also 
be important in pacing behaviors.
Description o f Female Mice Sexual Behavior
Female mouse sexual behavior varies from female rat sexual behavior.
Studies examining estrogen receptor knockout (ERKO) [45, 46] and progesterone
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receptor knockout (PRKO) [47,48] female mice and sexual behavior have described 
female mouse sexual behavior. Either wildtype [49, 50] or Swiss Webster [45, 51] 
males are used as stud males and there does not appear to be a difference in 
responsiveness from the female mice. The sexual tests can be conducted in the male 
home cage [45,46, 51] or a separate testing chamber [49, 50]. If tested in a separate 
chamber, stud males have to be habituated for one hour in the test chamber before the 
female is introduced [49]. Testing time varies but sessions are usually thirty minutes 
long [45, 46] or terminated after a specific quantity of stimulations, such as 15 
mounts [49].
Mounts in mice are defined as both male’s forepaws on the female’s rear [47]. 
Since the lordosis posture is not as rigid in female mice as in female rats, lordosis is 
defined in mice as all four paws being grounded, hind region elevated from the 
bottom of the test chamber and the dorsiflexion of the vertebral column. A lordosis 
quotient is calculated by dividing the number of lordosis postures by the number of 
mounts for each mouse [47]. Receptivity scores are calculated for each female mouse 
and are based on normal female behaviors such as squeaking, attempts to avoid 
mounts, rearing and kicking [47]. Receptivity scores given to wildtype females 
treated with estrogen and progesterone were approximately 65% and averaged 22 
total mounts and 15 mounts with intromissions [50]. Subjects also showed 20% 
rejection behavior [46], In addition to lordosis, sexual behavior in female mice also 
includes male and female approaches, female rejection behavior (fleeing, biting, 
kicking) and holding the still receptive posture with and without lordosis. During a 
thirty minute testing period female mice average approximately 35 sexual bouts
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which are defined as sexual behaviors occurring in succession by the male, female or 
both mice until the mice are separated for more than half a body length [46],
When studying sexual behavior in mice, there are noteworthy strain 
differences that must be accounted for, in addition to experimental factors.
Comparing the 129S6/Sv/Ev to the C57BL/6 strain is important because they are the 
parental strains of genetic mouse models [8 ]. When analyzing sexual behavior with 
these strains, several observations should be taken into account. When the female 
mouse is OVX, hormone replacement is necessary to achieve sexual behavior; 
however, estrogen alone will not induce high levels of lordosis and receptivity in 
either 129S6/Sv/Ev or C57BL/6 strains [48]. Administering progesterone along 
with estrogen to either strain results in high levels of sexual receptivity [48].
Lordosis quotients are higher for female mice primed with high doses of estrogen and 
administered progesterone than females primed with lower doses of estrogen [48].
To achieve maximal receptivity, both strains required weekly priming for six 
weeks with estrogen along with weekly testing[48]. However with equal hormone 
priming and testing, strain differences are still evident [48], When high levels of 
estrogen and progesterone are administered, C57BL/6 females respond better 
thanl 29S6/Sv/Ev [48]. After six weeks of hormone treatment and testing, C57BL/6 
mice have a LQ of approximately 80 while 129Sv/Ev mice have a LQ of 
approximately 60 [48]. Regardless of the strain, mice require sequential hormone 
treatment and testing experience to achieve maximal receptivity [48].
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III. Dopamine and its Pathways
Sexual behavior in rodents has been used to examine the relationship between 
hormones, neurotransmitters levels and behavior. Our lab, as well as others, has 
examined sexual behavior in female rats to learn more about the role of 
neurotransmitters and hormones on sexual behavior [17, 18, 52-54]. These 
experiments have used pharmacological approaches such as administering agonists or 
antagonists or surgical approaches such as lesioning specific brain regions. DA and 
its pathways have been shown to regulate other motivational and reward behaviors, 
such as drug seeking behaviors [55-60]. Since pacing behavior in rodents is a 
motivational behavior, this dissertation wanted to determine whether DA contributes. 
Dopamine Pathways
Mapping studies have estimated that DA constitutes eighty percent of the total 
brain catecholamine content [4], Nerve cells containing DA are found in relatively 
rostral parts of the brain, including midbrain, hypothalamus and olfactory bulbs, and 
their projections are both ascending and descending [4]. There are many forebrain 
efferents projecting from the midbrain DA cell groups, and the substantial overlap of 
the midbrain and forebrain projections is sometimes labeled the mesotelencephalic 
DA system [4].
The DA system is divided into numerous pathways [4]. However for the 
purposes of this research dissertation, only three will be briefly described, the 
mesostriatal, mesolimbic and mesocortical, and the periventricular and 
diencephalospinal pathways.
Mesostriatal Pathway
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Cells in the system originate in substantia nigra (ventral tegmental area 
(VTA)/A10 and A8  groups). The dorsal component (nigrostriatal pathway) ascends 
through the medial forebrain bundle followed by the internal capsule to innervate the 
caudate nucleus, and the putamen (collectively known as the striatum) [61]. There 
are approximately 10,000 DA cell bodies in A9 cell group on 1 side of the rat brain 
[62], however a single axon from one cell body can branch and result in many 
synaptic boutons in the striatum [63]. Numerous synaptic connections from the 
striatum make connections with medium sized spiny neurons that give rise to the 
output pathways of the striatum [64], The ventral component cells originate in the 
VTA and projects to the nucleus accumbens (Nacc) [61]. The ventral component 
plays an important role in the reinforcing properties of psychostimulants and possibly 
other drugs of abuse [55], DA cell bodies project to both the striatum and the Nacc 
and can have effects on motor functions.
Mesolimbic System
This pathway arises from the DA neurons in the VTA [61]. The VTA is 
adjacent to the more prominent DA cell population of the substantia nigra [61], The 
axons of these neurons project from the ventral tegmentum to limbic and cortical 
areas [61]. Specifically they ascend to hypothalamic tissue and distribute the axons to 
regions including the Nacc and prefrontal fields of the cerebral cortex [61], They also 
project to the septum, amygdala, hippocampus, nucleus of the diagonal band, anterior 
olfactory nucleus, and limbic cortical areas [56], (see Fig. 5)
The mesolimbic pathway constitutes a major part of the DA “reward” system 
[65]. This reward system is based on research that shows a DA surge in the Nacc,
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when an animal is exposed to drags of abuse [56]. It is also known that an animal 
will self stimulate to exhaustion if stimulatory microelectrodes are implanted along 
the trajectory of the medial forebrain bundle [56]. This evidence allowed the DA 
afferents to and from the Nacc, to be labeled as a “reward” system [56]. This system 
consists of DA cells in the VTA, being continually inhibited by GABA [56]. When 
disinhibited, DA is released and produces a reinforcement that is normally involved 
with natural rewarding stimuli such as food and sex [56]. When the term “reward” is 
used it is describes behaviors that make an animal exhibit a self-reinforcing behavior. 
Reward does not describe a euphoric feeling [56],
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Figure 5: Sagittal projection of the ascending dorsal noradrenergic bundle and 
the mesolimbic dopaminergic system depicting four lesion sites (upper panel). 
The lower panel displays a coronal section of the rat brain depicting three 6- 
hydroxydopamine injection sites into dopaminergic terminal fields that have 
been tested for their effects on cocaine self-administration. Coronal view 
corresponds to section A 8920. Reprinted from [66]
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Pariventricular and diencephalospinal systems
Cells bodies for these systems originate in the A ll  and are located in the
periventricular gray of the posterior and dorsal hypothalamus and the caudal thalamus
[4]. The local projections project to the medial thalamus and hypothalamic nuclei and
make up the pariventricular DA system [4], Some of the collateral branches of these
fibers form the diencephalospinal system [4], These branches descend through the
dorsal longitudinal fasciculus and terminate in the spinal dorsal gray and the
intermediolateral cell columns (where the sympathetic preganglionic neurons are
located) [4], Dual innervation of the periventricular system (hypothalamic) and
diencephalospinal system(sympathetic preganglionic cell groups) by the A11
dopaminergic neurons may allow for integrated control of central and autonomic
components of complex motivated behavior such as sexual behavior [4],
Dopamine Receptors
All DA containing neural pathways contain DA receptors. DA receptors have
at least six members, all belonging to the G protein coupled receptor superfamily
[65], Receptors are categorized as Dj-like and D2 -like [67]. Di and D5 comprise the
Di-like receptors and D2 , D3 , and D4 make up the D2-like receptors [67], The De
receptor is an isoform of D2 [67]. (see Fig. 6 )
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Di receptors
Di receptors are distinguishable from D2 receptors because of their ability to 
stimulate adenyl cyclase [68-70], (see Fig. 6 ) These receptors have seven membrane 
spanning domains [65], The highest density of the Di receptor is found in the 
termination areas of the mesostriatal system (striatum, Nacc and olfactory tubules) 
and substantia nigra [4], Intermediate levels have been found in some nuclei of the 
amygdala [4], Low Di levels are located in the neocortex, thalamus, cerebellum, 
hippocampus, septum and hypothalamus [4], Di receptors can have a low affinity or 
high affinity to agonists (including DA) because of receptor-G protein interactions 
[4], High affinity occurs when the receptor is complexed with a G protein [4], 
Antagonists do not differentiate between receptors complexed with a G protein and 
those that are not [4, 71],
D2 receptors
D2 receptors have been identified because of their high affinity for 
antipsychotic drugs and their ability to either inhibit or not affect adenyl cyclase. [67], 
(see Fig. 6 ) D2 human receptors have a 96% homology with rat D2  receptors [72].
As mentioned before, there are two isoforms of D2 receptors (D2L and D2 S). These 
two isoforms are produced from the same gene by alternative mRNA splicing with 
respect to the presence or absence of a stretch of 29 amino acids located on the third 
cytoplasmic loop of receptor [67]. Currently there is no evidence of any important 
pharmacological or functional differences between D2L and D2 S [4].
In rats, the highest levels of D2 binding have been found in the striatum, Nacc, 
olfactory tubercle, substantia nigra, pars compacta, and glomerular layer of olfactory 
bulbs [4], Intermediate levels have been found in the central nucleus of the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
24
amygdala, lateral septum and the superior colliculus [4]. It is also interesting to note
that in virtually all areas in which Dj and D2 receptor densities were directly
compared, levels of Di receptors were distinctly greater [73].
Figure 6: Summary of the molecular events that lead to dopamine release. An 
increase of Ca2+ (as shown by the smaller dots) within the cell is a common 
trigger for the release of a neurotransmitter. The diagram shows that the Di 
and D5 receptors activate (indicated by the +) adenylyl cyclase (AC) leading to 
the production of cAMP. The D2, D3, and D4 receptors, on the other hand, inhibit 
it, as indicated by the —] sign shown below.
cAMP is a second messenger that activates other molecules within a cell, causing 
the cell to undergo certain changes in response to the increased presence of 
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Dopamine Receptor Mechanisms
Low ejection currents of DA or the selective Di agonist SKF 38393 had no 
effect on spontaneous activity of striatal neurons, but potentiated the increase in firing 
produced by the excitatory amino acid glutamate [74, 75]. This type of 
neuromodulatory action may be a mechanism whereby DA from the nigrostriatal 
pathway can enhance the excitatory glutamatergic input from the neocortex to the 
striatum (the corticostriatal pathway). At high ejection currents, both DA and 
selective Di and D2  agonists mainly exert an inhibitory effect on spontaneous and 
glutamate-evoked nerve cell firing [75, 76]. However, some evidence shows that 
moderate stimulation of D2 receptors can elicit an excitatory rather than an inhibitory 
response [76, 77]. More studies are needed to determine how these mechanisms 
relate to behavior regulated by DA systems.
Dopamine autoreceptors
DA autoreceptors are found in terminals, cell bodies and dendrites of DA 
neurons [78]. (see Fig. 7) Activation of presynaptic (terminal) DA autoreceptors 
inhibits both DA synthesis and release. Activation of somotodendritic DA 
autoreceptors causes a reduction in cell firing, which secondarily reduces transmitter 
release in terminal areas [79]. Dendrites of DA cells in substantia nigra release DA 
[80] and such release is stimulated by membrane depolarization or amphetamine 
administration [80, 81]. Dendritic DA release can thus be presumed to be a source of 
stimulation of somotodendritic autoreceptors, thereby modulating neuronal impulse 
flow and terminate DA release [79]. Early research suggested that DA autoreceptors 
effects are mediated by receptors with a D2-like rather than a Dj pharmacology [82,
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83]. Some research suggests that DA autoreceptors are distinct from classic D2 
receptors [84, 85]. Action of both somotodendritic autoreceptors and presynaptic 
inhibitory autoreceptors is mediated by increased opening of potassium channels [8 6 , 
87] which hyperpolarizes the cell membrane and decreases the firing rate of DA 
release . In contrast, autoreceptor mediated inhibition of DA synthesis seems to occur 
via a reduction of c AMP-dependent activation of tyrosine hydroxylase in nerve 
terminals [8 8 , 89].
Autoreceptors are not found in all DA systems. In rats, autoreceptors appear to 
be on most ascending DA projections except for those terminating in prefrontal and 
cingulated cortices [90]. These differences may account for the higher firing rate of 
mesoprefrontal and mesocingulate fibers as compared with those of the mesostriatal 
system.
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Figure 7: Presynaptic and postsynaptic area of a DA ending. The key steps in the 
synthesis and degradation of DA and the sites of action of various psychoactive 
substances at the DA synapse.
1. Enzymatic synthesis. The conversion of tyrosine to DOPA 
(dihydroxyphenylalanine) by tyrosine hydroxylase is stimulated by L-DOPA 
and blocked by the competitive inhibitor a-methyltyrosine.
2. Storage. Reserpine and tetrabenazine interfere with the uptake and storage of 
DA by the storage granules. Reserpine is an effective antipsychotic drug; the 
depletion of DA by reserpine is long lasting and the storage granules appear to 
be irreversibly damaged. Tertrabenazine also interferes with the uptake and 
storage mechanism of the granules but only transiently.
3. Release. Amphetamine and tyramide enhance DA release from dopaminergic 
neurons by blocking reuptake. Amphetamine induces a psychosis that is 
reversed by psychoactive drugs.
4. Receptor interaction. Typical antipsychotics such as perphenazine and 
haloperidol are particularly effective in blocking the D2 and the presynaptic 
autoreceptors.
5. Reuptake. DA activity is terminated when DA is taken up into the presynaptic 
terminal. Amphetamines, cocaine and benzotropine are potent inhibitors of the 
reuptake mechanism.
6. Degradation. DA present in a free state within the presynaptic terminal can be 
degraded by the enzyme monoamine oxidase (MAO). Pargyline is an effective 
inhibitor of MAO. Some MAO is outside the dopaminergic neuron. DA can 
also be inactivated by the enzyme catechol-O-methyltransferase (COMT), which 
is believed to be localized outside the neuron in the postsynaptic cell.
Adapted from Kandel, Schwartz and Jessel 2000 [65]
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Dopamine receptor agonists and antagonists
Apomorphine (APO) is a general DA receptor agonist [71]. APO treatment in 
humans can cause nausea and vomiting. Clinically, it has been used as an emeric 
after oral ingestion of certain poisons or drug overdoses [71]. Fortunately, rats and 
mice are incapable of vomiting. The mode of action of APO is to stimulate D2 
mediated receptors in the chemical trigger zone of the medulla oblongata of the brain 
[71]. Even though APO seems to affect D2 mediated behavior effects, it is not overly 
selective for D2  over Di receptors [71]. APO has a higher affinity for presynaptic 
autoreceptors that for postsynaptic DA receptors [71]. Low does of APO diminish 
dopaminergic neurotransmission by selectively activating autoreceptors [4]. High 
doses stimulate dopaminergic functions by acting directly on postsynaptic receptors
[4].
Many drugs that are agonists and antagonists of DA are available (see [4] for 
details). DA general antagonists of DA include haloperidol, pimozide, and 
flupenthixol. Di receptor agonists include SKF38393, SKF81297, SKF82958, and 
SKF82526. Di antagonists include SCH23390 (also has an affinity for 5-HT2 
receptors), SKF83566 and NNC-112, NNC-756 and SCH 39166. D2 agonists include 
quinpirole and LY-163502, while D2 antagonists include sulpride and raclopride [4]. 
Behavioral Effects o f Apomorphine
Numerous studies have investigated APO’s effects on various behaviors [91- 
97]. For the purposes of this dissertation, the behaviors of interest are sexual and 
locomotor behaviors. Locomotor behaviors are important to study because 
copulatory behavior, specifically pacing, involves locomotor activity and are an
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essential part of pacing behavior. Generally, in both rats and mice, low doses of APO 
produce hypomotility and yawning, while higher doses produce stereotyped behaviors 
such as sniffing, licking and gnawing, [92], Higher doses of APO enhance locomotor 
activity in a biphasic way in C57 mice and increase climbing behavior [93]. 
Particularly, 3mg/kg of APO produced an increase in locomotor activity and climbing 
behavior in comparison with saline[98].
Self administered stimulation thresholds were measured in rats treated with 
five doses of APO and trained to press a lever that delivered electrical stimulation to 
the lateral hypothalamus [99]. Low doses caused thresholds to increase while the two 
higher doses caused thresholds to drop [99]. The authors hypothesized that the 
change in the direction of the behavioral effect corresponds with the shift in APO’s 
action from presynaptic activation to predominantly postsynaptic activation of DA 
receptors as the concentration of APO increases [99].
Rats administered low doses of APO showed increased yawning behavior 
which indicates activating of presynaptic DA receptors. Higher doses result in 
induced stereotyped sniffing and yawning which reflects an activation of pre and 
postsynaptic DA receptors [96]. The authors further investigated APO’s effect on pre 
and postsynaptic DA receptors by administering the Di receptor agonist SKF 38393. 
SKF 39393 inhibited yawning induced by low doses of APO [96]. However this 
effect can be attenuated if the rat was pretreated with specific Dj receptor antagonist 
SCH 23390 [96], High doses of APO induced sniffing and this effect was potentiated 
when rats were pretreated with SKF 38393 [96], These data indicate that Di receptor 
activation modulates both pre and postsynaptic effects of APO but the effect is in
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
opposite directions [96]. In a similar study, rats were treated for 21 days with the 
selective Di blocker SCH 23390. One, three, five and eleven weeks following the 
chronic treatment they received either a low hypomotility inducing dose or a high 
stereotyped behavior inducing dose of APO [97]. The rats always show an enhanced 
stereotyped response to the higher dose of APO, but never any change in their 
motility to the lower dose of APO [97]. The authors postulate that the results provide 
a behavioral correlate of the pre and postsynaptic modulation of APO by Dj receptors 
[97]. A critical dose of APO (300 micrograms/.kg s.c.) given immediately before 
placing rats into a novel environment produced initial sedation followed by enhanced 
locomotion [100]. When these same rats were treated with Di and D2 antagonists, the 
APO induced mobility response was inhibited, indicating that APO stimulation can be 
antagonized by Di as well as D2 receptor blockade[100]. However a high affinity for 
D2 receptors seems vital for the blockage of APO inhibition [100].
APO effects behavior [91-96,100], receptor activation [100]and DA 
metabolite levels [101, 102], Chronically stressed C57BL/6 mice treated with two 
doses of APO showed decreased climbing behavior and reduced DA metabolites, 
DOPAC, HVA and 3 -methoxytyramine (3-MT) concentrations in the caudate 
putamen and Nacc compared to non stressed mice. The authors suggest that chronic 
stress lead to a sensitization of mesolimbic DA presynaptic receptors possibly by an 
associated downregulation of postsynaptic DA receptors in the C57 strain [102],
Acute immobilization stress causes a significant reduction of spontaneous 
locomotion and a slight reduction of spontaneous climbing, while ten days of chronic 
stress decreased stress induced locomotion and increased stress induced spontaneous
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climbing [94], Twenty four hours after the last stressor, the results were reversed 
with increased locomotion behavior observed in the acutely stressed mice and 
decreased climbing behavior observed in the chronically stressed mice [94].
Following acute exposure to immobilization stress, DOPAC/DA and HVA/DA ratios 
were increased in the striatum and in the Nacc [101], Finally, chronically stressed 
mice tested 24 hours after the last stressful experience, showed an increased 
sensitivity to the inhibitory effects of low doses of APO on climbing behavior and a 
decreased sensitivity to the inhibitory effects of the same doses o f the DA agonist on 
locomotion [101]. These experiments show that APO can activate both pre and 
postsynaptic DA receptors depending on dose administered. In addition, stress can 
attenuate these APO induced behavioral changes which indicates that stress can 
modulate APO’s activation of pre and postsynaptic receptors [94,101].
Factors such as stress and dose are notable because they influence behavioral 
activation by pre and postsynaptic DA receptors. These factors can directly affect 
both pacing and receptive behaviors, causing unexpected increases or inhibition. 
Stress and dose are important to consider when examining the effects o f DA or APO 
on female mice copulatory behavior. Currently, there are reports that APO both 
facilitates [22] or inhibits [103] copulatory behavior in female rodents . The 
discrepancy in reports is probably due to the aforementioned factors.
Behavioral Effects o f Selective DA receptor agonists and antagonists
Systematic doses of Di agonists cause robust stimulation of grooming in rats 
[104]. Direct infusions to the striatum or Nacc can cause patterns of hyperactivity 
and stereotyped behavior. D2 agonists, quinpirole or RU 24213 cause increases in
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locomotion, sniffing, and snout contact [105-107]. These changes similar to APO 
behavioral effects but are not as robust. These effects can be blocked by both D2 and 
Di antagonists as well as endogenous DA depletion [106,108]. Combined 
administration of Di and D2 selective agonists cause more robust effects than either 
singly [106,109]. Both Dj and D2 selective antagonists can also cause catalepsy 
[110].
Dopamine, Estrogen and Progesterone
Administration of estrogen and progesterone to OVX female mice facilitates 
sexual behavior [48], Research has shown that estrogen and progesterone have 
genomic and nongenomic effects that are mediated by interacting with DA receptors, 
uptake sites, and DA levels [23, 111-121], Genomic effects have a long latency and 
require a specific hormone-receptor interaction, specifically translocation of the 
complex to the cell nucleus and subsequent induction of specific hormone-sensitive 
proteins [114] Nongenomic effects are rapid in onset, recoverable and stereospecific 
[114]. Both types of effects are important to mention in the context of this 
dissertation because the behavioral paradigm used as well as past research requires 
that OVX female rodents are administered estrogen and progesterone either acutely or 
chronically [1 , 1 1 ]
While the main focus of the current research was on DA concentrations in the 
striatum and Nacc because they are part of the mesolimbic “reward” system, the 
interaction between DA, estrogen and progesterone should also be considered. In the 
paradigm used in this dissertation, all animals were treated with estrogen and
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progesterone to initiate sexual behavior. Therefore, the interaction effects of 
hormones with DA, its metabolites and its receptors warrant further discussion.
Estrogen and DA
Estrogen replacement is essential to achieve maximal receptive behavior in 
OVX female rodents. Estrogen has genomic effects in the brain including inducing 
progesterone receptors that facilitate copulatory behavior. Several studies have 
investigated the interaction between estrogen and DA levels [115, 122], receptors 
[120,123]and transporters [117] in the mesolimbic DA system . When the female rat 
is OVX, extracellular DA concentrations and DA transporter density decreases [103, 
122] and Di receptor density is decreased compared to gonadally intact rats [123]. In 
comparison, high affinity D2 receptor sites increase and supersensitivity of striatal D2 
receptor binding sites develops over 2-3 months [120].
When estrogen is administered to OVX rats, there is a rapid release of DA in 
the striatum, an increase in striatal DA turnover and a downregulation of D2 receptors 
in the striatum [118, 124], Acute estrogen has also been shown to act directly on the 
Nacc to enhance potassium stimulated DA release [114], In vivo voltammetry shows 
that local injections of 17B-estradiol produce rapid and dramatic increases in 
stimulated DA overflow in the Nacc [114]. When a physiologically dose is given 
acutely to OVX female rats, DA turnover is increased in both the striatum and Nacc, 
while DA concentrations remain the same [118]. OVX females treated with chronic 
estrogen show a reduction of DA concentrations in both the striatum and Nacc, and 
no effect on DA turnover [121], Although there is less research on estrogen effects in 
the Nacc, research suggests that the mechanisms are similar to the striatum [121].
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When DA transporter levels were compared in short term versus long term 
OVX female rats before and after treatment with estrogen, several interesting results 
were found [117]. Compared to intact females, both short and long term OVX 
females showed a significant decrease in DAT density in the striatum, and the long 
term OVX females also showed a decrease in the Nacc [117]. DAT density was 
restored in striatum but not in the Nacc, of short term OVX females that were treated 
with estrogen [117]. Estrogen treatment did not change the DAT density levels in 
the striatum of the long term OVX females but it did restore levels in the Nacc [117], 
This information is relevant to this dissertation for several reasons. All female 
mice used in these experiments were OVX and administered estrogen both acutely 
and chronically. The length of time that females were OVX before they receive 
hormones directly affects DA levels, its receptors and transporters. In view of the 
fact that this dissertation research measured DA, receptors and metabolites in the 
striatum and Nacc, the time between the ovariectomy and the estrogen administration 
is critical.
Progesterone and Dopamine Interactions
Several studies show that estrogen induced progesterone receptors mediate 
progesterone effects on sexual behavior in rodents [47, 48]. Progesterone receptors, 
like estrogen receptors are ligand inducible members of a superfamily of transcription 
factors that undergo significant conformational change upon ligand binding [47], 
Studies using progesterone receptor antagonists and protein synthesis inhibitors 
consistently demonstrate the mediating role of intracellular progesterone receptors on 
sexual behavior[48] [47]. Progesterone’s genomic effect on sexual behavior was
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demonstrated in these studies [47]. However there is also evidence that progesterone 
has nongenomic effects on sexual behavior, possibly mediated through effects at the 
membrane [47], The minimal receptivity response of progesterone receptor knockout 
mice (PRKO) given progesterone implies that membrane bound progesterone is not 
the primary mediator of the lordosis response in mice [47]. Instead, evidence suggests 
that intracellular genomic effects act together with membrane receptor effects to 
mediate sexual behavior in rodents [47].
Progesterone receptors are of particular interest because of their interaction 
with DA [125]. DA induced sexual behavior in mice requires an unoccupied 
progesterone receptor [47]. Positive correlations have been demonstrated between 
receptor concentrations in the hypothalamus and the maximal behavioral response, 
results which demonstrate the requirement for elevated levels of progesterone 
receptor for behavioral responsiveness to progesterone in mice [125].
Experiments with hormone primed PRKO have suggested crosstalk between 
progesterone receptors and DA [125]. Wildtype and PRKO were administered the Di 
agonist, SKF 39393, but only wildtype female mice exhibited high levels of 
lordosis.[125] The PRKO showed minimal responses to both progesterone and Di 
agonists [125]. These results suggest that progesterone receptors mediate DA’s 
contribution to sexual behavior. [125].
DA is released in the striatum when estrogen primed female rats are treated 
with progesterone [9], Furthermore after estrogen priming, a membrane associated 
protein with a high affinity for progesterone has been isolated from the striatum [9]. 
These effects of progesterone on striatal DA release are not seen without estrogen
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priming [9]. Studies comparing the effect of repeated estrogen with either acute 
estrogen or progesterone treatment find prior exposure to estrogen enhances the 
effects of subsequent estrogen or progesterone treatments on AMPH-stimulated DA 
in dialysates from the dorsal lateral striatum[9]. In addition, significant increases of 
DA in the Nacc and striatum occurred concurrently with DA release in the VMN in 
the female during copulation [9].
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IV. The Role of Dopamine in Sex Behavior
DA is a mediating factor in sexual behavior, specifically for incentive, 
motivation and reward. When sexually sluggish male rats are administered APO (a 
general DA agonist), copulatory behavior increases [126]. Sexually active male rats 
administered haloperidol (general DA antagonist), display decreased sexual behavior 
and motivation [127], APO injected into the ventral tegmental area (VTA) delays 
onset of copulation and slows its rate. These males showed fewer complete 
copulatory behaviors (mounts, intromissions), and more misdirected copulatory 
attempts, implicating that the VTA affects motor but not motivational aspects of male 
rat sexual behavior [128, 129].
Experiments that administered selective DA agonists and antagonists in the 
medial preoptic area of male rats found the following results: the D2 agonist, LY- 
163502 delayed the onset of copulation and slowed the rate of copulation [130]. A 
reduced number of vaginal intromissions were required to reach ejaculation [130]. 
The Di agonist, SKF-82526 had no effect alone or in combination with LY-163502 
[130]. The Di antagonist SCH-23390 delayed the onset of copulation and decreased 
ejaculatory threshold (the number of vaginal intromissions required to trigger 
ejaculation) [130]. A low dose of D2 agonist alone and with the Di antagonist 
delayed onset of copulation and reduced ejaculatory threshold [130]. This data 
suggests that stimulating D2 receptors or blocking Dj receptors delays onset of 
copulation and reduces ejaculatory threshold. Overall, this data indicates that DA, or 
its agonists, increase receptivity. Additionally stimulation of Di receptors increases 
receptivity, while stimulation of D2 receptors decreases receptivity [130]
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Additional studies have shown that the Di antagonist, SCH-23390 and the D2 
antagonist, raclopride injected into the medial preoptic area (MPOA) decreases the 
sexual motivation of male rats [131]. Additional evidence of DA modulating sexual 
behavior comes from work examining extracellular DA in the mPOA [132]. In male 
rats, there are changes in DA release during copulation in brain areas that play a role 
in reward and motivation aspects [132], Specifically, DA is released in the mPOA 
during copulation and in other DA pathways during encounters with a receptive 
female [132]. These dopaminergic pathways underlie the motivational and reward 
aspects of sexual behavior. Specific increases are found in the nigrostriatal system, 
which enhances readiness to respond to stimuli as well as the mesolimbic system, 
which is critical for numerous types of motivation [133]. As mentioned previously, 
there are also increases in the mPOA which focuses motivation onto specific sexual 
targets, increases copulatory rate and efficiency, and coordinates genital reflexes 
[134]. The increase of DA in these three areas generally enhances sensorimotor 
integration by removing tonic inhibition. Therefore, steroid hormones increase the 
responsiveness of certain neurons but only after DA removes tonic inhibition.
Ascending DA projections to the Nacc are also involved in sexual behavior of 
the male rat. Several studies show an increase in DA in the Nacc of the male rat 
during sexual behaviors [135,136] and it is important to determine if similar changes 
occur in females during sexual behavior. Extracellular DA increases in the Nacc of 
male rats during copulation as well as during exposure to stimuli that has been 
previously associated with a receptive female [135,136], These data suggest that, in
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the male rat, DA release in the Nacc is associated with incentive or motivational 
behavior.
Findings that DA increased in both the mPOA and the Nacc during sexual 
behavior led researchers to examine if this effect occurs in female rats. DA 
transmission in female rats has not been studied as extensively as in male rats. In 
studies examining DA in the mPOA during female sexual behavior, DA levels were 
increased when a hormone primed female became receptive as well as when 
copulating with a male [137], The increase of DA during copulation only occurred 
when the male and female were confined in the same arena [137]. However, when 
the female was allowed to pace her contacts with the male, no increase in DA was 
seen in the female mPOA during copulation [137]. DA levels in MPOA were also 
measured in vivo during sexual activity after priming with estrogen and progesterone. 
DA levels increased when females were primed with low levels of estrogen and given 
500 pg of progesterone. Further increases in MPOA DA occurred when females 
copulated in non pacing chambers, and when they were allowed to pace, DA 
metabolites rose during copulation [137]. Single unit activities, recorded from Type 
1 neurons in POA of female rats while copulating, were increased when the female 
rats initiated proceptive behavior [19]. Type 2 neurons showed brief activity when 
the male mounted [19], Type 3 neurons fired in response to intromission, and type 4 
were inhibited throughout lordosis [19]. Type 1-3 neurons were recorded from the 
transitional regions between the medial and lateral POAs [19]. Type 4 neurons were 
located more medially in the medial POA. Systemic injections of pimozide (a DA 
receptor blocker) diminished firing in type 1 neurons and abolished proceptivity [19].
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The firing pattern in type 1 neurons appears to represent the motivational state of rat 
and has implications for consummatory value of penile intromission [19].
The role of DA transmission in both the striatum and Nacc has also been 
examined in estrogen and progesterone primed hamsters. Vaginocervical stimulation 
was correlated with elevated DA levels in the Nacc [138]. Estrogen treated female 
rats also had enhanced increases of DA in Nacc compared to vehicle treated females 
[2]. DA levels, in striatum, increased more in OVX, hormone primed, female rats 
that paced copulation than in female rats that did not pace copulation [3]. Female 
rats that paced also showed a greater increase of DA in Nacc [3]. Lesions of the 
striatum reduces pacing and lesions to the shell of the Nacc causes failure of females 
to initiate sex prior to a sexual contact [139].
Results from numerous studies have shown an important modulatory role of 
DA on sexual behavior in female rats. These results have lead to this investigation of 
the regulatory role o f DA on sexual behavior in female mice. Further investigations 
using mice will broaden the understanding of the role of DA in female sex behavior. 
Moreover, the possibility of investigating behavior in mice, which overexpress 
(transgenic) or do not express (knockout) specific components of DA neurons, 
provide a unique advantage of a mouse model. Establishment of a mouse model will 
allow further exploration of the regulatory roles of DA and its receptors on the reward 
system involved with sexual behavior. This new model will compliment current 
pharmacological studies already existing in with rats. The combination of 
information from rats and mice models may increase understanding of evolutionary 
and genetic differences underlying neural mechanisms of behavior.
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V. Research Design and Methods - General Experimental Design
Animals
Animals used in this series of experiments were six week old C57BL/6N Tac 
or 129S6/Sv/Ev black female mice. Subjects were OVX at Taconic Farms prior to 
arrival at the Hunter College Animal Facility. Subjects were doubly housed with 
food and water ad lib and maintained on a 12-hour light/dark cycle. To ensure that 
males were larger than females, twelve week old Swiss Webster males served as stud 
males. Males were housed individually and received food and water ad lib.
Injections
Each female received injections of 10 pg estradiol benzoate 48 and 24 hours 
before testing and 500 pg progesterone five hours before testing. These injections 
have been shown, in both rats [7, 139] and mice [46, 47, 50], to induce sexual 
receptivity. None of the males received injections.
Pacing Apparatus
The pacing apparatus consisted of the male’s home cage with the addition of 
two Plexiglas cubes with a small opening. The openings are large enough for the 
female, but not the male, to enter and exit. The male’s home cage is thirteen 
centimeters high, eighteen centimeters wide and twenty-nine centimeters long. Both 
the male and female had access to the entire cage. However, only the female had 
access to the inside of the cubes, but the males frequently tried to enter the cubes and 
sat on top of the cubes. The pacing cubes remained in the male’s homecage during 
the testing session and were removed following completion of testing. During 
testing, the male’s homecage was covered with Plexiglas instead of the wire top.
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This change ensured that the subjects would not be distracted by food, water or 
climbing on the cage top. Because mice are exploratory, it was necessary to 
acclimate them to the chamber prior to testing. Pacing cubes remained in the 
female’s homecage from a week after their arrival until they were sacrificed. This 
procedure allowed acclimation to the cube and ease of traversing through the small 
opening. The male was exposed to the pacing cubes five hours prior to testing, so 
that the male would be interested in the female, not the cubes, during sex behavior 
testing.
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Figure 8: Pacing Chamber for Mice. Two chambers are shown. Each chamber 
consists of the male’s homecage to which two Plexiglas cubes have been added, 
the cubes have small openings that only the female can fit through. The cubes 
allow the female an escape mechanism so that she can approach and withdraw 
from the male when desired. The top of the cage is replaced with a Plexiglass 
cover.
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Behavioral Testing
Five hours after injection of progesterone, behavioral testing began. The 
pacing apparatus was placed in the male’s home cage five hours prior to testing. The 
female was then placed in the male’s homecage and the behavioral test began. All 
testing sessions were videotaped for behavioral scoring. Two observers recorded the 
exit latencies; return latencies after interactions such as mounts, intromissions and 
ejaculations as well as the number of mounts, intromissions and ejaculations and 
number of rejections. Exit latencies are the time it takes the female to leave and 
reenter the male chamber after stimulations. All sessions lasted thirty minutes or 
until ejaculation occurred. The percentage time in the male chamber, the percentage 
time in the pacing cubes, the percentage of leaves after each type of stimulation, the 
average time spent with the male, the average time spent in the pacing cubes, and the 
percentage of exits after stimulation were also calculated.
Each female was tested once a day, every four days with a maximum of two 
consecutive tests. All tests were performed under red light during the dark portion of 
their circadian cycle. After completion of testing, the female mice were sacrificed by 
rapid decapitation and their brains frozen on dry ice for further neurochemical 
analysis.
Monoamine Analysis
Brains were sectioned at 250-300pm at -6 to -8° C in a microtome cryostat. 
Nacc, striatum, ventral medial nucleus, vertical diagonal band and amygdala brain 
areas were micropunched from sections according to the atlas of Franklin and Paxinos 
[140] with a 500 pm diameter cannula while the slide rested on a microscope stage
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which was maintained at -  11.5° C as described by Luine et al., 1999 [141], The 
monoamines and metabolites DA, DOPAC, HVA, serotonin, 5HIAA and 
norepinephrine were measured. Punched samples were placed in 1.5 ml Ependorf 
tubes with 60 pi of sodium acetate buffer containing a-methyl-DA (as internal 
standard). After freezing-thawing and centrifugation, the supernatant was removed 
and 2 pi of 1 mg/ml ascorbate oxidase solution (Sigma) was added to each sample to 
minimize the HPLC front. Forty microliters was injected into a Waters Associates 
chromatographic system consisting of a Waters 2690 Separation Module, and 
Symmetry Cis-5 pm column. An ESA 5011 Colocomb 3100A electrochemical 
detector with the screening electrode set at +0.05 V and the detecting electrode at 
+0.35 Y was used. Concentrations of neurotransmitters and metabolites were 
calculated by reference to standards using peak integration with a computer assisted 
Water Millennium system. Sample runs averaged 30-40 minutes. The pellet was 
dissolved in 100 pi of 0.2 N NaOH for protein determination by the Bradford method. 
Concentrations were expressed as pg/pg protein [141].
Statistical Analysis
The behavioral data was scored and the number of mounts, intromissions, 
ejaculations, rejection behavior, returns latencies after each stimulation, total percent 
time spent with the male, total time spent in the neutral pacing cubes, exit latency, 
exit after stimulation and total exits after each type of stimulation for each female 
mouse were calculated. Descriptive statistics including the mean and standard error 
were obtained for each measure. One way ANOVA was used analyze data when a 
between subjects design was used and different groups of mice were treated with
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
4 6
different drugs or doses of the same drug. If ANOVA was significant at the p < 0.05 
level, appropriate post hoc test were used to test differences between groups. Linear 
regression was used to correlate neurotransmitter levels to the number of stimulations 
received. Correlations at the p < 0.05 level were accepted as significant.
VI. Experiment 1 -  Establishment of a Pacing Paradigm for Female Mice
Rationale
Extensive research has examined sexual behavior of female rats and shown 
that DA levels increase in specific brain areas when female rats are allowed to pace 
and copulate [2, 3, 9]. In comparison, little research has focused on sexual behavior 
of female mice. Data from female mouse studies will complement already existing 
pharmacological data from female rats. When a pacing paradigm for female mice is 
developed, it can be used with transgenic and knockout mice. 129S6/Sv/Ev females 
were selected for these experiments because knockouts are developed from 129 and 
C57 lines.
Specific Aims
1. Establish and quantify baseline pacing and receptive behavior in female 
mice.
2. Determine monoaminergic neurotransmitters that influence pacing.
Hypotheses
1. Female mice will pace in a manner similar to other small rodents.
2. DA and its metabolites, DOPAC and HVA, will increase in the striatum and 
Nacc when female mice are allowed to pace and copulate.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
4 7
Animals
Female mice of a 129S6/Sv/Ev or C57BL/6N Tac background were used.
Injections
Female mice of the 129S6/Sv/Ev and C57BL/6N Tac were hormone primed 
with 10 pg of estrogen 24 and 48 hours before testing and 500 fig of progesterone 
five hours before testing.
Behavioral Testing
The subjects were tested as described in the general experimental methods. 
Monoamine Analysis
Immediately following testing, brains removed, sectioned, micropunched and 
analyzed using HPLC analysis as described in the general experimental methods. 
Statistical Analysis
Linear regression was used to correlate relationships between total stimulations and 
monoamine levels in the striatum, Nacc, VDB, and VMN as described in the general 
experimental methods.
Results
Female mice of the 129S6/Sv/Ev were not suitable for behavioral analysis 
because they were lethargic and exhibited low levels of copulatory behavior. These 
subjects showed little interest in the male and rarely used the pacing cubes. In 
addition, they showed low receptivity (few mounts or intromissions) (data not 
shown). Therefore C57 female mice were utilized for the rest of the experiments.
This strain is also appropriate because they are used to create knockout mice. 
Apparatus
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Several apparatuses were evaluated for quantification of mouse pacing. The 
first attempt used a scaled down version of an established apparatus for testing of rat 
pacing [7] (see Fig 9a). This apparatus consisted of a chamber with Plexiglas barrier 
with three enter/exit holes that were too small for the males to fit through but were 
large enough for the females.
This apparatus was not suitable for analysis of mouse pacing. The females 
would traverse back and forth through the enter/exits holes when they were without 
the male. However, when males were place n the chamber, many females would sniff 
at the holes, but never cross to the male side. Other females would cross to the male 
side but they never crossed back to the female side; thus they did not display pacing 
behavior. The greatest problem was that persistent males would attempt to cross 
through the enter/exit holes. Some males succeeded at squeezing through the holes, 
but others became stuck in the holes and had to be removed.
This apparatus was modified by removing the holes and substituting a solid 
wall of Plexiglas (see Fig. 9b). This Plexiglas barrier was raised above the bottom of 
the cage, and allowed for the females but not the males to fit under. Similar problems 
were encountered as in the first design. Some females would stick their head under 
the barrier, but not completely cross over to the male side. Other females crossed 
over to the male side but never crossed back over to the female side. Finally, some 
persistent males tried to cross over to the male side and became stuck under the 
barrier.
Though these first two apparatuses failed, a consistent trend was noted. 
Though the females did not use the enter/exit holes or the barrier to escape the male,
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they did display other behaviors. Specifically, if  the male approached a female and 
who was unwillingly to be mounted, she would crouch in a comer of the cage and 
reject him by kicking and rearing up on her hind legs. This strategy worked 
temporarily, but if  the male was persistent, he could eventually push her out of the 
comer and overpower her.
Observing this interaction, a new apparatus that utilized the rejection behavior 
was devised (see Fig 9c). Plexiglas boxes (7 cm width, 6  cm height, and 7 cm depth) 
with small enter/exit holes that the female, but not the male, could fit through were 
constructed. These boxes were placed in two diagonal comers of the cage and 
allowed the female to escape the male, if  desired. If the male attempted to follow her 
into the box or put his head into the box, she could kick or nip him to keep him away. 
Also, the Plexiglas box protected females from being pushed out of the comer. This 
configuration proved to be the best way to measure pacing behavior in female mice. 
The small boxes gave females an escape mechanism from the male and allowed the 
female to approach and withdraw from the male when she desired.
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Figure 9a: Scaled down version of an established apparatus for testing of rat pacing. This 
apparatus consisted of a chamber with Plexiglas barrier with three enter/exit holes that were too 
small for the males to fit through but were large enough for the females.
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Figure 9b: Modified pacing apparatus for testing of mouse pacing. This apparatus was modified 
by removing the holes and substituting a solid wall of Plexiglas. The Plexiglas barrier was 
raised above the bottom of the cage, and allowed for the females but not the males to fit under.
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Figure 9c: Successful apparatus used in experiments. Plexiglas boxes (7 cm width, 6 cm height, 
and 7 cm depth) with small enter/exit holes that the female, but not the male, could Fit through 
were constructed. These boxes were placed in two diagonal corners of the cage and allowed the 
female to escape the male, if desired.
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Behavioral Measures in Pacing Females
Utilization of C57 females and Plexiglas escape cubes in the male home cage 
enabled measurement of female mouse pacing behavior. Pacing behavior in female 
rodents differs by species and most research has been done on pacing female rats (see 
Table 1). However, a description of female mice pacing behavior is also necessary 
and important to further understand female rodent copulatory behavior. Female mice 
pacing consists of entering and exiting two pacing cubes, which have a small 
enter/exit hole on one side to allow the female to escape and approach the male at 
will. In addition to entering and exiting the pacing cubes, the female mice also use 
rejection behavior, which consists of kicking, nipping and biting the male if he 
approaches her before she is ready to copulate. The pacing cubes, combined with the 
rejection behavior allow the female mouse to pace her copulations by providing an 
escape mechanism which allows her to control the amount and frequency of 
stimulation she receives from the male. Observations from this experiment have 
illustrated that female mice use both the pacing cubes and rejection behavior to 
escape the male. Therefore quantifying both the frequency of utilizing the cubes as 
well as the frequency of rejection behavior displayed provides an accurate assessment 
of pacing behavior in female mice. Pacing is quantified by calculating the latencies 
to return to the male after receiving a mount, intromission or ejaculation, total number 
of rejections and latency to return to the male after rejection behavior. The total 
amount of time spent with the male and in the pacing cubes is also calculated.
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Table 1: Comparison of average Pacing Measures between Female rats and Mice. 
Mean and SEM. All latencies were measured in seconds.
1. Unpublished observations reported by Luine et a l . , 1998 [142]
2. Observations reported by Erskine, 1989 [7]
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As shown in results, receptivity in female mice differs from receptivity in female rats. A 
female rat is receptive if she displays the lordosis posture in response to a male mount, which 
allows the male to successfully copulate [7]. Therefore, quantifying the frequency and quality of 
lordosis (calculating a lordosis score) serves as a measure of receptivity. Female mice do not 
consistently display the lordosis posture, which means that lordosis can not be easily used to 
measure receptivity. Instead, a female mouse is considered to be receptive if she remains still 
and allows the male to mount and intromit, without showing rejection behaviors. For the 
purposes of this series of experiments, female mice receptivity was categorized as low, medium 
and high. This categorization was developed from previous and current observations of female 
mouse sexual behavior in our laboratory (see Table 2).
Table 2: Evaluation of Female Mice Receptivity
This ranking system was developed to determine if a female mouse is displaying low, 
medium or high levels of receptivity. Data was derived from behavioral tests using 
estrogen and progesterone treated OVX mice using the mouse pacing paradigm of 
small Plexiglas cubes in the male homecage.
Behavior Low Medium High
Mounts 0 - 1 2-5 6 +
Intromissions 0 - 1 2-4 5+
Ejaculations 0 0 1
Rejection Behavior 5+ 2-4 0 - 1
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Monoamine and Metabolite Levels in Pacing Females
OVX females received estrogen and progesterone treatment and were tested for 
sexual behavior. Immediately following behavioral testing, mice were rapidly 
decapitated and their brains collected and frozen. Brains were sectioned at 250-300 pm 
and micropunched as described in the general experimental methods. Levels of 
monoamine levels and their metabolites (DA, DOPAC, HVA, HVA/DA 5-HT, 5-HIAA, 
NE) were measured in the striatum, Nacc, VMN, and amygdale using HPLC analysis 
described in the general experimental design. Thought not significant, a trend was seen 
between total stimulations (mounts plus intromissions) and DA, HVA, and DOPAC 
levels in the Nacc (see Fig. 10). However, we did not find any other significant 
correlations or trends between any other monoamines and amount of stimulations or 
pacing parameters (see Figs. 11-13).
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Figure 10: Levels of DA and metabolites in nucleus accumbens plotted versus total 
stimulations. Each data point represents one mouse, (n = 6). There was a 
significant correlation between DA and total stimulations (r 1,4 = 0.68, p < 0.05). 
The correlation was not significant for metabolites and total stimulations including 
DOPAC and total stimulations (r2 1, § = 0.22, p = 0.30), and HVA and total 
stimulations (r2 1,5 = 0.10, p = 0.49).
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Figure 11: Levels of monoamine and metabolites in Amygdala plotted versus total 
stimulations. Each data point represents one mouse, (n = 5). There was no 
significant correlation found between the monoamine or metabolite levels and total 
stimulations in amygdala. This includes DA levels and total stimulations (r2i,4 =
0.02, p = 0.77), NE levels and total stimulations ( r2 1,4 = 0.11, p = 0.51), DOPAC 
levels and total stimulations ( r\ 4  = 0.13, p = 0.47), 5HIAA levels and total 
stimulations (r2 1,4) = 0.06, p = 0.64), HVA levels and total stimulations (r2i,4 = 0.12, p 
= 0.50), 5HT levels and total stimulations (r2 1 ,4  = 0.00, p = 0.98), HVA/DA levels and 
total stimulations (r2 1 ,4  = 0.05, p = 0.65), and 5MAA/5HT levels and total 
stimulations (r2̂  = 0.37, p = 0.20).
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Figure 12: Levels of monoamine and metabolites in VDB plotted versus total 
stimulations. Each data point represents one female mouse, (n = 6). There was a 
positive correlation between 5HIAA/5HT levels and total stimulations in VDB 
(r2 1 ,5  = 0.69, p < 0.02) There was no significant correlation found between the 
monoamine or metabolite levels and total stimulations in VDB. This includes DA 
levels and total stimulations (r2 1 ,5  = 0.01, p = 0.78), NE levels and total stimulations 
(r2 1.5 = 0.00, p = 0.91), DOPAC levels and total stimulations (r2 1,5 = 0.04, p = 0.65), 
5HIAA levels and total stimulations (r2i,s) = 0.13, p = 0.42), HVA levels and total 
stimulations (r2 1 ,5  = 0.05, p = 0.61), 5HT levels and total stimulations (r2 1 ,5  = 0.04, p 
= 0.66), HVA/DA levels and total stimulations (r2 1 ,5  = 0.19, p = 0.33).
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Figure 13: Levels of monoamine and metabolites in VMN plotted versus total 
stimulations. Each data point represents one mouse, (n = 5). There was no 
correlation found between monoamine levels and total stimulations in VMN. This 
includes DA levels and total stimulations (r2 1,4 = 0.02, p = 0.80), NE levels and total 
stimulations (r2 1,4 = 0.10, p = 0.55), DOPAC levels and total stimulations (r2 1,4 = 
0.10, p = 0.53), 5HIAA levels and total stimulations (r2 1,4) = 0.01, p = 0.82), HVA 
levels and total stimulations (r2i,4 = 0.01, p = 0.86), 5HT levels and total stimulations 
(r2 is4 = 0.00, p = 0.89), HVA7DA levels and total stimulations (r21,4  = 0.00, p = 0.94), 
and 5HIAA/5HT levels and total stimulations (r2 1,4  = 0.07, p = 0.62)
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Discussion
The results from this experiment demonstrated that female mice will pace when a 
suitable apparatus is used. Female mice pace at a lower rate compared to female rats 
(see Table 1). Observations of a lessened rate of pacing and receptivity as compared to 
female rats may be due to the amount of habituating sessions and hormone treatments. 
Hormonal treatments and habituating sessions were based on female rat behavior. In 
subsequent experiments, it was discovered that both the male and female mice need at 
least three training sessions to begin to show ample copulatory behavior. Studies 
examining sexual behavior in PRKO mice have shown that optimally, female mice need 
approximately six weeks of weekly hormone treatments and testing sessions to achieve 
maximal copulatory behavior [47], while rats only need a maximum of two hormone 
treatments and one training session before displaying maximal copulatory behavior [7]. 
The experiments discussed above were conducted before information regarding the 
optimal hormone and practice levels to achieve maximal copulatory behavior in mice was 
published. The mice in this experiment were not trained or administered hormone 
treatments for six weeks, which may explain why the female mice displayed low levels of 
receptivity (5 or more mounts and 6  more intromissions) compared to other experiments 
where female mice average 22 mounts and 15 mounts with intromissions [50].
Males, rats or mice undergo a “stud versus dud” test to determine if they will be 
suitable stimulus males for the experiment. If they do not show adequate copulatory 
behavior (mounts and intromissions) after three sessions with receptive females; they are 
not used with for experiments. Vigorous sexual behavior is important because the 
experimental females can show high levels of rejection behavior. If the stud males are
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
6 6
not good copulators, they will stop attempting copulation with the experimental females.
Male and female mice must also be acclimated to the pacing apparatus prior to 
testing. If they are not, they will spend the majority of the testing session exploring the 
pacing cubes instead of engaging in copulatory behaviors. The low levels of receptivity 
and pacing behavior observed in this experiment may be attributed to lack of prior 
habituating sessions and adequate hormone treatment. In subsequent experiments, more 
habituation sessions and higher hormone doses were given and greater behavior was 
found, (see subsequent experiments)
This experiment also examined monoamine levels in the striatum, Nacc, vertical 
diagonal band, amygdala and VMN in female C57 mice. A positive correlation was 
found between DA, DOPAC and HVA and total stimulations in the Nacc. These results 
are consistent with previous results showing that DA mediates copulatory behavior in 
female rats and hamsters [2, 24]. Previous research has shown elevated DA levels in the 
striatum and Nacc when rats or hamsters are allowed to copulate [3, 138]. These 
increases were even larger in the striatum and Nacc when females were allowed to pace 
their copulations. [2] [139] [3].
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VII. Experiment 2 -  Effects of Apomorphine (20 fig, 60 fig and 120 fig) Pacing 
and Receptive Components of Copulatory Behavior in C57 Female Mice
In the previous experiment, a method for measuring pacing behavior in female 
mice was established. Using this method allowed for several observations. The first is 
that female mice do pace in a similar manner, but at a lesser rate, than female rats (see 
Table 1). In addition, consistent with previous rat studies we found that DA and its 
metabolites increased in the Nacc as a function of sexual stimulations received (see Fig 
10). This pattern indicated that DA in the Nacc, has a mediating role in copulatory 
behavior in female mice. Numerous female rat studies report similar results [2, 3, 139]. 
DA increases in both the striatum and Nacc when females have been exposed to male rats 
as well as when allowed to pace copulation [2,3, 9,122,139].
APO is a general DA agonist that binds to both Di and D2 receptors and can be 
used to examine the role of DA in regulating behaviors. Various doses of APO were 
administered (2 0 , 60, 1 2 0  pg) and motivational and receptive components of copulatory 
behavior of female mice were measured.
Specific Aim
Assess the role of DA and its receptors in specific brain areas on receptive and 
motivational aspects of sexual behavior.
Hypothesis
Previous studies examining DA levels during copulation have found that DA 
increases in the striatum and Nacc during paced copulation [2, 3, 139]. Therefore it is 
hypothesized that administering APO, the DA receptor stimulating drug, to OVX female 
mice will cause an increase in pacing and receptive behavior.
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Animals
Four groups of 7-14 OVX female C57 mice were used. The first group received 
saline and served as controls. The rest received 20 pg, 60 pg, or 120 pg of APO. Animal 
care is outlined in the general experimental methods.
Injections
All female mice received 10 pg of estrogen 48 and 24 hours before testing and 
500 pg of progesterone five hours before testing. Each group received a subcutaneous 
injection of APO or saline 15 minutes before behavioral testing began.
Experimental Methods
The behavioral testing methods are outlined in the general experimental methods. 
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p < 
0.05, Fishers LSD, a post hoc test, was used to test specific differences between groups. 
Results
Using the receptivity chart (see Table 2), all groups treated with APO displayed 
low to medium levels of receptivity while the control group displayed high levels of 
receptivity. The group treated with 60 pg APO received significantly fewer mounts than 
the control group (Ty 41 = 2.90, p < 0.05) (see Fig 14). Intromissions were also decreased 
groups treated with APO, but this effect did not reach statistical significance.
Pacing was generally increased by APO. The group treated with 120 pg of APO 
spent significantly more time in the neutral cubes after receiving an intromission than the 
control group, the 20 pg APO group and the 60 pg APO group (p3 ; 13 = 6.83, p < 0.05) 
(see Fig 15). Other measures of pacing did not show a statistically significant increase.
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Figure 14: The effects of apomorphine on receptive behaviors. Data are mean ± SE 
number or percentage of stimulations after treatment with saline, 20 pg, 60 pg or 
120 pg of APO (n = 7 to 14 per group). Data were analyzed by one way ANOVA. 
Fishers LSD, post hoc test, showed that the group treated with 60 pg of APO 
received significantly less mounts than the control group (F3,4i = 2.90, p < 0.05).
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Figure 15: The effects of apomorphine on pacing behaviors. Data are mean ± SE 
number or percentage of stimulations after treatment with saline, 20 pg, 60 pg or 
120 pg of APO (n = 7 to 14 per group). Data are analyzed by one way ANOVA. 
Fishers LSD, post hoc test, showed that the group treated with 120 pg of APO spent 
significantly more time in the neutral cubes after receiving an intromission than the 
control or other treatment groups (F3 , 13 = 6.83, p < 0.05).
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Discussion
Previous studies in female rats found increases in both pacing and receptive 
behavior when dopamine levels increased [2, 3, 9, 20, 22, 122], Data from this 
experiment partially agreed with the results of those studies. The results illustrated that 
APO is associated with a dose dependent increase in pacing behavior (see Fig. 15), but a 
dose dependent decrease of receptive behavior (see Fig. 14). Specifically the group 
treated with 120 pg of APO spent significantly more time in the neutral cubes after 
receiving an intromission than the control and other treatment groups. Although not 
significant the group treated with 120 pg of APO spent more time in the neutral cubes 
after receiving a mount, less time overall with the male and a greater percentage of time 
overall in the neutral cubes (see Fig. 15).
Pacing parameters increased with APO treatment however receptivity decreased, 
particularly at the 60 pg dose. The group treated with 60 pg of APO received 
significantly less mounts than the control group. While not significant, the group treated 
with 60 pg of APO also received less intromissions compared to the control group. The 
dose dependent increase in pacing behavior seen at the 1 2 0  pg dose and dose dependent 
decrease in receptivity seen at the 60 pg dose indicates that receptive parameters are more 
sensitive than pacing parameters.
These relationships in the data may be explained by considering APO’s affinity 
for pre and postsynaptic DA receptors and consequent effects on behavior. Generally, 
low doses of APO produce hypomotility while higher doses induce stereotyped behavior 
[92]. The dose dependent behavior may be related to the higher affinity of APO for 
presynaptic DA receptors than for postsynaptic DA receptors. At lower doses, APO acts
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as an antagonist by activating presynaptic receptors. This causes an inhibition of both DA 
synthesis and release [4], At higher doses, APO activates both presynaptic and 
postsynaptic receptors, increasing transmission and therefore acting as an agonist [4],
The activation of pre and postsynaptic behavior by APO has been shown with 
other behaviors. Self administration stimulation thresholds were measured in rats treated 
with five doses of APO and trained to press a lever that delivered electrical stimulation to 
the lateral hypothalamus [99]. Experiments examining the effects of increasing doses of 
APO on thresholds of self administered electrical stimulation to the hypothalamus found 
a significant behavioral difference at the lower doses versus the higher doses [99]. Low 
doses caused thresholds to increase while the two higher doses caused thresholds to 
decrease [99]. The authors indicate that increased thresholds at lower doses may reflect 
APO activating presynaptic receptors, which leads to an inhibitory effect and causes 
more stimulation to be necessary to have the same effect. Subsequently, the higher doses 
cause thresholds to decrease which indicates the shift of APO from activation of 
presynaptic receptors to postsynaptic receptors. This change in receptor stimulation 
causes less stimulation to result in the same effect [99]. Another study examining the 
effect of APO on locomotor activity found that there is a significant behavioral difference 
between low and high doses of APO [96]. Low doses induced yawning which reflected a 
selective activation of presynaptic DA receptors, while higher doses induced stereotyped 
sniffing and yawning indicating postsynaptic D2  receptor activation [96].
Presynaptic behavioral inhibition as well as inhibition of DA release may 
underlie the decrease in receptivity induced by a lower dose of APO (60 pg).
Hypomotility and decreased locomotor behavior may cause the female to display less
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
73
receptive behaviors. In addition, decreased receptivity can lead to increased pacing 
because the female is now utilizing the cubes to withdraw and escape the male. Higher 
doses of APO are recruiting postsynaptic receptors which will lead to increased DA 
synthesis and release. The increase in pacing behavior was seen in the highest dose (120 
pg) of APO. In the current experiments with female mice and past experiments with 
female rats [2, 3], increased DA release is correlated with increased pacing behavior, 
inferring that pacing is a rewarding behavior. An increase in DA may explain past 
studies which reported that both male and female rats treated with APO showed an 
increase in receptive behavior [20, 22,128, 129], however we did not see this change in 
behavior. When female mice were administered higher doses of APO (180 pg), we 
expected to see further increases in pacing behavior and increases in receptive behavior. 
However, no changes were found in either pacing or receptive behavior (unpublished 
observations).
Mechanisms which could account for these differences in the behavioral 
responses to APO between rats and mice are unknown. However, in the next section 
(Experiment 3), levels of DA and metabolites as well as other mononamines were 
measured in brain areas of treated mice in order ot better understand effects o f APO.
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VIIL Experiment 3 -  Effects of APO (20 pg, 60 pg and 120 pg) of APO to female 
mice to examine neurochemical changes
Rationale
Experiment 2 showed significant behavioral differences between subjects treated 
with APO compared to control subjects (see Figs. 14-15). Subjects treated with higher 
doses of APO showed increased pacing behavior but decreased receptive behavior, as 
compared to controls. These differences in behavior may be attributed to the activation 
of pre and postsynaptic DA receptors. APO has a higher affinity for presynaptic DA 
autoreceptors than postsynaptic DA receptors and therefore at low doses, acts as an 
antagonist and decreases DA transmission [4]. At higher doses DA transmission is 
increased because APO acts as an agonist by acting on postsynaptic receptors [4],
These behavioral results could also be due to monoaminergic changes, 
particularly DA level changes in the striatum, Nacc and VMN which are induced by 
APO. Therefore, DA and metabolites were measured in brain areas after 20, 60, and 120 
pg of APO. Monoaminergic changes may underlie the increases in pacing behavior and 
decreases in receptive behavior caused by APO and the differences in the behavioral 
responses between rats and mice.
Specific Aims
Assessment of effects of various doses of APO on DA levels and metabolites in 
the striatum and Nacc, areas responsible for pacing, and VMN, area responsible for 
receptivity.
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Hypothesis
Experiment 3 showed treatment with APO caused a dose dependent increase in 
pacing behavior and a dose dependent decrease in receptive behavior. Receptivity was 
more sensitive to apomorphine than pacing because receptivity decreased at 60 pg while 
pacing increased at 120 pg. It is hypothesized that the treatment groups, specifically the 
group treated with 120 pg will have higher levels of DA in the Nacc and striatum than the 
control groups, while the group treated with 60 pg of APO will have higher levels of DA 
in the VMN.
Animals
Four groups of 6-10 OVX female C57 mice were used. The first group received 
saline and served as controls. The rest received 20 pg, 60 pg, or 120 pg of APO. Animal 
care is outlined in the general experimental methods.
Injections
All mice received 10 pg of estrogen 48 and 24 hours before sacrifice and 500 pg 
of progesterone five hours before sacrifice. Each group received a subcutaneous 
injection of APO or saline 30 minutes before sacrifice.
Experimental Methods
No behavioral tests were given. Thirty minutes after injection with APO or 
saline, the mice were sacrificed by rapid decapitation. Brains were quickly frozen for 
neurochemical analysis.
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p < 
0.05, Fishers LSD, a post hoc test, was used to test specific differences between groups.
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Monoamine analysis
Brains were sectioned, micropunched, and analyzed for monoamine and 
metabolite levels using HPLC analysis as outlined in the general experimental methods.
Results
The results illustrate several significant findings in the striatum, Nacc and VMN. 
HVA/DA was significantly affected by APO treatment, and the group treated with 120 
pg of APO had significantly lower HVA/DA levels in the striatum than the control and 
the group treated with 60 pg of APO (F 3.33 -  4.99, p < 0.005) (see Fig 16). Serotonin 
was also affected by APO treatment and the groups treated with 20 pg and 60 pg of APO 
had significantly lower serotonin (5-HT) levels in the striatum than the control and group 
treated with 120 pg of APO (F 3 ,3 2  = 6.32, p < 0.001) (see Fig 17). In the Nacc, 120 pg 
of APO treatment significantly increased DA levels as compared to both the control and 
60 pg groups (F 3> 23 ~ 5.57, p < 0.005) (see Fig 18). Groups treated with 20 and 120 pg 
APO had significantly lower HVA/DA levels in the Nacc than the control group (F 3 ,2 3  = 
3.66, p < 0.02) (see Fig 18). Finally, the group treated with 60 pg of APO had 
significantly higher HVA levels in the VMN that the groups treated with 20 pg and 120 
pg (F 3 , 2 0  = 2.95, p < 0.05) (see Fig 19). DA and DOPAC in the VMN showed a similar 
pattern of change following APO, but the difference did not reach statistical significance.
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Figure 16: The effects of apomorphine on DA and metabolites in striatum. Data 
are expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are analyzed 
by one way ANOVA. Fishers LSD, post hoc test, showed that HVA/DA levels were 
significantly lower in the group treated with 120 pg of APO compared to both the 
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Figure 17: The effects of apomorphine on NE, 5-HT and metabolites in striatum. 
Data are expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are 
analyzed by one way ANOVA. Fishers LSD,post hoc test, showed the groups 
treated with 20 and 60 pg of APO have significantly lower 5-HT levels than the 
control group and group treated with 120 pg of APO (F 3 ,3 2  = 6.32, p < 0.001).
Norepinephrine
5 . 3  1 .0 -







Control 20 pg Apo 60 pgA po 120 pg Apo 
T reatm ent
5HIAA
Control 20  jig Apo 60 pg Apo 120 pg Apo 







I I m m  n
"  HI 1
Control 20 pg Apo 60 pg Apo 120 pg Apo 
T reatm ent
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7 9
Figure 18: The effects of apomorphine on DA and metabolites in Nacc. Data are 
expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are analyzed by 
one way ANOVA. Fishers USB, post hoc test, showed the group treated with 120 pg
APO had significantly higher levels of DA (F 3 ,23 = 5.57, p < 0.005) and significantly 
lower levels of HVA/DA along with the group treated with 20 pg of APO (F 3 , 2 3  =  
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Figure 19: The effects of apomorphine on DA and metabolites in VMN. Data are 
expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are analyzed by 
one way ANOVA. Fishers LSD,post hoc test, showed the group treated with 60 pg 
of APO had significantly higher levels of HVA in the VMN compared to groups 
treated with 20 pg and 120 pg of APO (F 3 , 2 0  = 2.95, p < 0.05).
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Discussion
Treatment with APO led to a number of dose dependent changes in monoamines 
in the striatum, Nacc and VMN. The group treated with 120 pg of APO had significantly 
higher levels o f DA in the Nacc and significantly lower HVA/DA levels in the striatum 
and Nacc compared to controls. The group treated with 60 pg of APO had significantly 
higher HVA levels in the VMN that the groups treated with 20 pg and 120 pg. The 
groups treated with 20pg and 60 pg of APO had significantly lower serotonin levels in 
the striatum than the control and group treated with 120 pg of APO.
These monoaminergic results support the hypothesis and may provide an 
explanation for the behavioral results from Experiment 3. Again, the results of 
experiment 3 illustrated that APO caused a dose dependent increase in pacing behavior 
(see Fig 15) and a dose dependent decrease in receptive behavior (see Fig 14). In this 
experiment the group treated with 120 pg APO had significantly higher levels of DA in 
the Nacc (see Fig 18), while that same dose induced significantly higher pacing behaviors 
(see Fig 15). In addition, they had significantly lower HVA/DA levels in both the 
striatum and Nacc (see Figs 16,18). The increase in Nacc DA and the decrease in the 
HVA/DA ratio indicate that APO induces increased DA release and that DA is not 
metabolized as rapidly as in controls (i.e. a decrease in turnover). Increased DA levels in 
the Nacc along with increased pacing agree with previous reports with female rats that 
pacing caused increased levels of DA in Nacc. The decrease in HVA/DA in the striatum 
at the 120 pg dose of APO may have also contributed to the increased pacing of this 
group [2, 3,139].
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It is notable that treatment with 60 jig of APO was associated with a significant 
increase o f HVA levels in the VMN (see Fig. 19) because this group also displayed the 
lowest levels of receptivity, (see Fig 14) Inhibition of lordosis in female rats has 
previously been correlated with increases of DA in the ventromedial hypothalamus [143, 
144] Therefore the decreased receptivity displayed by this group may be due to the 
increased activity of DA in this area.
APO treatment led to a u-shaped dose-response curve for 5-HT levels in the 
striatum: in the two lowest doses, 5-HT was decreased as compared to controls and the 
high dose of APO (see Fig. 17). 5-HT has an inhibitory effect on lordosis but this effect 
is centered in the VMN [145, 146]. No changes in the VMN 5-HT were noted. Striatal 
5-HT and DA interact in some aspects of psychoactive drug effects [147,148]. However, 
the pattern of these changes does not correlate with pacing changes. Thus, possible 
relationships of striatal 5-HT to the behaviors measured, if  any, are unknown.
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IX. Experiment 4 -  APO effects on locomotion
Rationale
Experiment 2 demonstrated that APO had a dose dependent inhibitory effect on 
receptive behavior and a facilitatory effect on pacing behavior. This pattern could be 
explained by noting APO’s dose dependent activation effect on pre and postsynaptic 
receptors [4]. At low doses, presynaptic DA receptors are activated while at high doses, 
postsynaptic DA receptors are activated [4], Results of DA and metabolite measurements 
in Experiment 3 were consistent with this hypothesis. However activation of pre and 
postsynaptic receptors can also affect locomotor behavior [96], Specifically APO can 
affect ambulations, grooming and stereotypy [92, 93].
While pacing behavior is a copulatory behavior [7] it also consists of locomotor 
behavior since the female must approach and withdraw from the male. APO effects on 
locomotor behavior, could have a profound effect on the female’s ability to pace 
effectively. Therefore investigation of APO effects on locomotor behavior in female C57 
mice is important for understanding the changes in copulatory behavior. In this 
experiment the same doses (20 pg, 60 pg, and 120 pg) used in previous copulatory tests 
were used to examine the effect of APO on locomotor behavior in an open field 
apparatus. In addition, measures for exploration and anxiety were also made.
Specific Aim
Determine the effects of APO (20 pg, 60 pg, and 120 pg) on locomotor behavior in 
female mice.
Hypothesis
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Locomotor activity, exploration and anxiety will be correlated with APO dose, and 
changes may be related to pacing or receptivity.
Animals
Four groups of 8 OVX female C57 mice were used. The first group received 
saline and served as controls. The rest received 20 pg, 60 pg, or 120 pg of APO. Animal 
care is outlined in the general experimental methods.
Injections
All mice received 10 pg of estrogen 48 and 24 hours before testing and 500 pg of 
progesterone 5 hours before testing. Each group received an injection of APO or saline 
15 minutes before behavioral testing began.
Experimental Methods
Mice were first acclimated to the task by placing them on the open field apparatus 
for 15 minutes. The open field apparatus is a square (45cm by 45 cm), green, Plexiglas 
open field. The height of the four wails of the field is 20 cm. The field consists of a 4 by 
4 grid and each grid is 10.5 cm by 10.5 cm.
Drug treatment and open field tests began 4 days after initial acclimation. 
Tabulations were made for grid visits, rears (mice standing on hind legs), wall climbs 
(mice standing on hind legs and placing front paws on wall), grooms (scratching and 
cleaning fur) and defecations.
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p < 
0.05, Fishers LSD, a post hoc test, were used to test specific differences between groups. 
Results
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All behavioral measures were altered in a dose-dependent manner by APO, and 
significant differences were found in several of the locomotion measures following APO 
treatment. Outer visits were increased by APO, and the group treated with 120 pg of 
APO had significantly more outer visits than the control or group treated with 20 pg of 
APO (F3, 28 ~ 4.34, p < 0.01) (see Fig 20). In contrast, inner visits, a measure of anxiety, 
were decreased by APO. The groups treated with the highest doses of APO, 60 pg and 
120 pg, had significantly less inner visits than the control group (F3> 28 = 5.01, p < 0.006) 
(see Fig. 21). All groups treated with APO displayed significantly less rearing behavior 
than the control group (F3; 28 = 16.66, p < 0.0001). Rearing is related to exploration. The 
groups treated with 60 pg and 120 pg of APO displayed significantly less grooming than 
the control group (F3; 2 8 = 8.28, p < 0.004) (see Fig. 21). Finally, the group treated with 
120 pg of APO displayed significantly less wall climbs than the control group (F3> 28 -  
5.15, p < 0.005) (see Fig. 21).
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Figure 20: The effect of apomorphine on outer visit in open field apparatus. Data 
are mean ± SE number of outer visits after treatment with saline, 20 pg, 60 pg or 
120 pg of APO (n = 8 per group). Data were analyzed by one way ANOVA. Fishers 
LSD post hoc test, showed the group treated with 120 pg of APO had significantly 
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Figure 21: The effect of apomorphine on inner visits in open field apparatus. Data 
are mean ± SE number of inner visits after treatment with saline, 20 pg, 60 pg or 
120 pg of APO (n = 8 per group). Data were analyzed by one way ANOVA. Fishers 
LSD post hoc test, showed the groups treated with 60 pg and 120 pg had significantly 
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Figure 22: The effects of apomorphine on rearing behavior, wall climbing and 
grooming behavior. Data are mean ± SE number of rears, wall climbs and 
grooming behavior after treatment with saline, 20 pg, 60 pg or 120 pg of APO (n = 8 
per group). Data were analyzed by one way ANOVA. Fishers LSD post hoc test, 
showed all groups treated with APO (20 pg, 60 pg and 120 pg) displayed 
significantly less rearing (F^as = 16.66, p < 0.0001), while the groups treated with 60 
pg and 120 pg APO showed significantly less grooming behaviors (F3,28 = 8.28, p < 
0.004) than the control group. The group treated with 120 pg displayed significantly 
less wall climbing behavior ( F3,28 = 5.15, p < 0.005) than the control group.
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Discussion
The results support the hypothesis that behaviors on an open field, especially 
locomotion behavior would be correlated with APO dose. Outer visits increased with 
increasing APO doses, and the data showed a significant increase in outer visits, which is 
a measure o f locomotor activity, in the group treated with the 120 pg of APO compared 
to controls (see Fig 20). In contrast, APO significantly decreased rearing and wall 
climbing, which are measures of exploratory behavior, compared to controls (see Fig 22). 
APO also significantly decreased the number of inner visits, an indirect measure of 
anxiety behavior [149], in the groups treated with 60 pg and 120 pg APO compared to 
controls (see Fig. 21). Finally APO decreased grooming behavior in the groups treated 
with 60 pg and 120 pg compared to controls (see Fig 22).
APO generally induces increased locomotion and stereotyped behavior such as 
sniffing and licking at high doses [94]. At lower doses, APO can induce hypomotility 
[92], however in C57 mice APO enhances locomotor activity [93]. The current data 
suggests that APO had a significant excitatory effect on locomotor activity (outer visits). 
However, APO had an inhibitory effect on exploratory behavior and grooming behavior. 
In addition APO increased anxiety levels (decreased inner visits). Comparing the number 
of inner visits in an open field behavior is an indirect measure of anxiety, but not an 
anxiety test [149]. This conclusion based on observations that rodents generally do not 
like wide open areas since they are more susceptible to predators. Instead they prefer a 
dark, enclosed area or in the case of the open field the area which is close to the 
wall [149].
In a previous experiment examining APO’s effect on pacing and receptive 
behavior, a dose dependent increase in pacing behavior and a dose dependent decrease in
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receptivity were seen. The same dose of APO (120 pg) was associated with an increase 
in locomotor activity (outer visits) and an increase in pacing behavior. Thus, changes in 
pacing behavior parallels increased outer visits in the open field paradigm. In addition a 
dose dependent decrease (60 pg) in receptivity was seen in Experiment 2 and there is a 
significant increase in anxiety (decreased inner visits) at the same dose in this 
experiment. The increase in anxiety may be related to the significant decrease in 
receptivity. If the female mouse is anxious, she may not show be able to remain still and 
allow the male to mount. Thus, less receptive behaviors may be shown. In addition, 
because of enhanced anxiety, she may show increased rejection behaviors such as 
nipping and kicking the male [47].
Anxiety was also increased following 120 pg of APO. This dose also 
significantly increased pacing behavior. The increased anxiety level may also contribute 
to increased pacing behavior, because subjects spend more time inside the cubes to 
escape the male. The mounting or intromitting of the female by the male may further 
increase anxiety levels and cause additional increased pacing behavior (retreating to the 
safe neutral cubes). Increased anxiety levels in conjunction with increased locomotor 
activity can lead to increased pacing behavior, but not decreased receptive behavior as 
seen at the 60 pg dose. Enhanced locomotion would not contribute to the immobilization 
required for lordosis. Decreased exploration (rearing and wall climbing) and grooming 
may also indicate increased anxiety levels which may also lead to increased pacing and 
decreased receptivity.
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X. Experiment 5 -  Effects of specific Dj agonists and D2 agonists on copulatory 
behavior in female mice.
Rationale
The previous three experiments have examined the effect of APO on copulatory 
and locomotion. APO is associated with a dose dependent increase in pacing behavior 
and a dose dependent decrease of receptive behavior. In addition, APO caused increased 
locomotion, increased anxiety and decreased exploration. The observed behaviors may 
be due to APO activating presynaptic and postsynaptic receptors which induce different 
behaviors. In addition the role of Di and D2 receptors needs to be further investigated 
because they have been shown to modulate pre and postsynaptic effects [96].
Di and D2  receptor activation also differentially effects sexual behavior in rodents 
[23, 24,130,131]. Treatment with Di agonists had no effect on male sexual behavior 
[130], but when substituted for progesterone in female rats, increased lordosis [23]. In 
addition, administration of D2 agonists decreased receptivity in both male and female rats 
[23,131]. The current experiment investigates the role of specific Di and D2  agonists on 
pacing and receptive behavior in female mice.
Specific Aims
Determine the effects of Di and D2 receptors on pacing and receptive sexual behaviors in 
mice.
Hypotheses:
Administering Di agonists will increase receptive but not pacing behavior. Administering 
D2 agonists will decrease both receptive and pacing behaviors.
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Animals
Seven groups of OVX female C57 mice were used. The first group received 
saline and served as controls. Three groups received increasing (0.3,1.0, and 2.0 mg/kg) 
doses of SKF 38393 (Dj agonist) [4] and three groups received increasing doses (.03, 0.1, 
0.3 mg/kg) of quinpirole (D2  agonists) [4]. Animal care is outlined in the general 
experimental methods 
Injections
All mice received 10 pg of estrogen 48 and 24 hours before testing and 500 pg of 
progesterone 5 hours before testing. Each mouse is assigned to either the control group 
or one of the eight treatment groups and received either an injection of SKF 38393, 
quinpirole or saline 15 minutes before behavioral testing began.
Experimental Methods
The behavioral testing methods are outlined in the general experimental methods. 
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p <  
0.05, Fishers LSD, a post hoc test, was used to test specific differences between groups.
Results
There were no significant differences found between Di and D2 treated subjects 
on any of the pacing or receptive measures. The group treated with the low dose of 
quinpirole spent a higher percentage of time after receiving an intromission with the male 
than the group treated with the medium dose of quinpirole (F s, 119 = 3.28, p < 0.008) (see 
Fig. 26). There were no significant differences found between any of the remaining 
groups on either of the receptive parameters including mounts (F6, 125 ~ 0.71, p = 062)
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and intromissions (Fgs 125 = 0.54, p = 0.75) (see Fig. 23). There were also no other 
significant differences found between any of the groups on any of the pacing parameters 
including time spent with the male (F 6 , 1 2 5 =  1 -27, p = 0.28), time spent in the neutral 
cubes (F e, 125 -  1.43, p -  0.22), mount latency (F g; 125 = 0.77, p = 0.57), time spent with 
the male after receiving a mount (F g, 1 2 5 = 1.74, p = 0.15), time spent in the neutral cubes 
after receiving a mount ( F  ̂125 -  1.60, p = 0.18), percentage of times females exited 
after receiving a mount ( F 6,125 -  1.22, p = 0.31), intromission latency ( F 6,119 = 1.57, p 
= 0.17), time spent with the male after receiving an intromission (F g, 119 ~ 1.43, p =
0.22), time spent in the neutral cubes after receiving an intromission ( F gjig = 1.05, p = 
0.39) (see Figs. 24-26).
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Figure 23: The effect of Di and D2 agonists on receptive parameters. Data are 
mean ± SE number of stimulations after treatment with saline, SKF-38393 and 
quinpirole (n = 18-20 per group). The control group is represented by the solid bar. 
The groups treated with the Di agonist are represented by the open bars. The 
groups treated with the D2 agonists are represented by the hatched bars. Data were 
analyzed using a one-way ANOVA. Treatment with SKF 38393 or quinpirole had 
no effect on mounts ((F^ns = 0.71, p = 062) or intromissions (F<j, 125 = 0.54, p = 0.75).
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Figure 24: The effect of Dj and D2 agonists on percentage time spent with the male 
or in the neutral cubes. Data are mean ± SE percentage time after treatment with 
SKF 38393 or quinpirole (n = 20 per group). The control group is represented by 
the solid bar. The groups treated with the Di agonist are represented by the open 
bars. The groups treated with the D2 agonists are represented by the hatched bars. 
Data were analyzed by one way ANOVA. Treatment with SKF 38393 or quinpirole 
had no effect on time spent with the male (F 6, 1 2 5  = 1.27, p = 0.28), time spent in the 
neutral cubes (F 6,125 = 1.43, p = 0.22)
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Figure 25: The effects of D* and D2 agonists on pacing parameters associated with 
mounts.
Data are mean ± SE percentage time after treatment with SKF 38393 or quinpirole 
(n = 20 per group). The control group is represented by the solid bar. The groups 
treated with the Di agonist are represented by the open bars. The groups treated 
with the D2 agonists are represented by the hatched bars. Data were analyzed using 
a one-way ANOVA. Treatment with SKF 38393 or quinpirole had no effect on 
pacing parameters associated with mounting including mount latency (F 6 , 125 =  0.77, 
p = 0.57), time spent with the male after receiving a mount (F 6,125 = 1.74, p = 0.15), 
time spent in the neutral cubes after receiving a lhount ( F 6 , 125 = 1.60, p = 0.18), 
percentage of times females exited after receiving a mount ( F 6 , 125 = 1.22, p = 0.31)
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Figure 26: The effects of Di and D2 agonists on pacing parameters associated with 
intromissions. Data are mean ± SE percentage time after treatment with SKF 38393 
or quinpirole (n = 20 per group). The control group is represented by the solid bar. 
The groups treated with the D* agonist are represented by the open bars. The 
groups treated with the D2 agonists are represented by the hatched bars. Data were 
analyzed using a one-way ANOVA. If ANOVA was significant at p < 0.05 level, 
Fishers LSD tested specific differences. Fishers LSD,/>as* hoc test, showed the 
group treated with the low dose of the D2 agonist spent a significantly higher 
percentage of time with the male after receiving an intromission than the group 
treated with the medium dose (F 6, 119  = 3.28, p < 0.008). There were no other 
significant finding on any intromission pacing parameters including intromission 
latency (F  6,119  = 1.57, p = 0.17), time spent with the male after receiving an 
intromission (F 6, 119 — 1.43, p = 0.22), time spent in the neutral cubes after receiving 
an intromission ( F 6,119 = 1.05, p = 0.39)
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Discussion
In Experiment 2 which examined APO’s mediating effects on copulatory 
behavior, subjects treated with 120 pg of APO showed a dose dependent increase in 
pacing behavior, while subjects treated with 60 pg of APO showed a dose dependent 
decrease in receptive behavior. Di and D2 receptor involvement was hypothesized to 
have regulating effects, but further investigation was needed. Pacing and receptive 
behaviors were measured following Di and D2 agonist treatment. Dose dependent 
increases in receptive behavior were expected after treatment with SKF 38393 [23] and 
dose dependent decreases in both receptivity and pacing were expected after treatment 
with quinpirole [23, 131]. However none of these expected changes were seen in either 
pacing or receptive behaviors. The group treated with the low dose of quinpirole spent 
significantly more time with the male after receiving a mount than the group treated with 
the medium dose (see Fig. 26). There were no other significant differences found in any 
of the pacing or receptivity parameters between any of the treatment groups (see Figs. 23- 
26). Several explanations may account for the results and they are discussed below.
Studies demonstrate that Di receptors mediate both pre and postsynaptic DA 
receptors [96]. Examining the effects of Di agonists on APO induced behavior has 
shown that Di agonists have different effects on low versus high doses of APO [96]. The 
authors indicate that low doses of APO induce yawning which reflects a selective 
activation of presynaptic DA receptors; while high doses of APO induce stereotyped 
sniffing which reflects postsynaptic D2 receptor activation. SKF 38393, a Dj receptor 
agonist, inhibited yawning induced by low doses of APO [96], The inhibitory effect of 
SKF 38393 on APO induced yawning was attenuated by pretreatment with specific Di 
receptor antagonist SCH 23390 [96], However, SKF 38393 potentiated sniffing induced
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by the high doses of APO, without affecting gnawing [96]. These results indicate that Di 
receptor activation modulates both pre and postsynaptic effects of APO in opposite 
directions [96], The authors imply that Di receptor activation decreases presynaptic 
effects but increases postsynaptic effects. When presynaptic DA receptors are stimulated 
DA synthesis is inhibited by blocking the activity of tyrosine hydroxylase, the rate 
limiting step in catecholamine synthesis [90, 150, 151]. In addition, presynaptic DA 
receptor activation blocks DA release from presynaptic membrane-enclosed storage 
vesicles and attenuates the firing rate of DA neurons [150,151]. Activation of Di 
receptors inhibit presynaptic DA receptors activity, resulting in increased DA synthesis 
and release [4]. When postsynaptic DA receptors are stimulated, DA transmission 
increases. Therefore Di receptor activation of postsynaptic DA receptors may further 
increase DA transmission.
When female rodents are allowed to pace their copulations, DA levels are 
increased in the striatum and Nacc [2, 3,139]. This observation infers that paced 
copulation is rewarding. However if there is already an increased level of DA available, 
paced copulations may not be necessary, therefore pacing may not increase as it is no 
longer needed for reward. This relationship may explain why increased pacing and 
receptive behavior was not present as the doses of SKF 38393 increased. If the 
increasing doses of SKF 38393 increased DA synthesis and release, by inhibiting 
presynaptic activity and stimulating postsynaptic activity, then receptive and pacing 
behaviors may no longer have any additional rewarding value.
D2 receptors also modulate pre and postsynaptic receptor activity. An experiment 
examined the effects of Di and D2 activation on pre and postsynaptic activity [100].
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Administering APO immediately before placing rats into a novel environment produced a 
diphasic motility response (initial sedation followed by enhanced locomotion) [100]. 
Administering Di and D2 receptor antagonists can block APO induced inhibition of 
locomotor behavior [100]. Antagonizing APO inhibition requires a higher affinity for D2 
receptors [100]. Generally activation of D2 receptors causes locomotor inhibition [100]. 
Therefore increased D2 binding and activation is needed to display increased locomotor 
behavior [100].
As previously indicated, there was no difference on either pacing or receptive 
behaviors within the groups that received quinpirole. This result may be due to the fact 
that the doses were not high enough to bind and activate sufficient D2 receptors to inhibit 
behavior. The doses were intentionally kept low so undesirable behaviors such as 
immobility would not be induced [4], In addition D2 receptor activation of pre and 
postsynaptic receptor activity must be considered. Because of the low doses used, there 
may not have been enough available quinpirole to bind the needed amount of D2 
postsynaptic receptors and induce an increased behavioral effect. If the doses are 
inducing greater presynaptic receptor activity, there will either no change or a decrease in 
behavior.
Generally when D2 agonists were administered to female rodents, copulatory 
behavior was decreased [23, 131], The doses used in this experiment were based on 
experiments with rats investigating the effects of quinpirole on sex behavior and 
locomotion [131]. Similar results were expected in this experiment. D2 binding and 
presynaptic D2 activity is necessary to induce an inhibitory effect, while increased D2 
binding is required to induce an excitatory effect. The low doses of quinpirole may not
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why inhibition of pacing and receptivity was not seen. Though not measured in this 
experiment, the lack of D2 binding may explain the lack of pacing and receptivity 
inhibition.
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XI General Discussion and Conclusions
There were five experiments completed for this dissertation. Each gave 
information that was important and furthered understanding of how monoamines mediate 
copulatory behavior in the female mouse. Experiment 1 resulted in development of a 
pacing paradigm for female mice and was used to determine baseline pacing and 
receptive behaviors. Generally, female mice pace in a similar manner but at a lesser rate 
than female rats. However, unlike female rats that show the lordosis posture when tested 
after a small number of hormone treatments [12], female mice need weeks of hormone 
treatments to show receptive behaviors [47], In addition, female mice demonstrated 
increased DA levels in the Nacc as receptivity increased. Increases in DA levels in the 
Nacc seen in this experiment as well as others [2,3], led to further investigation of DA 
and its metabolites mediating pacing and receptivity.
APO was used to manipulate DA levels and investigate the resulting effect 
on pacing and receptive behavior. Female mice were treated with three doses of APO (20 
pg, 60 pg and 120 pg) and behavioral tests were conducted. Treatment with 120 pg of 
APO caused increases in pacing while treatment with 60 pg caused decreases in 
receptivity. The increased pacing behavior agreed with data from previous studies with 
female rats [3,139] and hamsters [24], but the decreased receptive behavior did not. The 
dose dependent relationships seen in the data may be explained by considering APO’s 
affinity for pre or postsynaptic DA receptors. Low doses of APO are relatively selective 
for presynaptic DA receptors which inhibit DA synthesis and release, while higher doses 
of APO are relatively selective for postsynaptic DA receptors which have an excitatory 
effect on DA transmission and release [4]. The lower doses may have only activated
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presynaptic DA receptors which may underlie the decreased receptivity seen at the 60 pg 
dose. The higher doses may have activated postsynaptic DA receptors which may 
underlie increased pacing behavior.
The results are also supported by the dopamine hypothesis of reward. The 
hypothesis states that both priming and reinforcing effects o f rewarding brain stimuli 
seem to be at least partially DA dependent [152]. Priming is defined as the motivating 
effect of “free” reward given before an instrumental act [152]. Experiments have shown 
that DA and DA agonists can prime food, cocaine and heroin seeking behaviors [152]. 
The 120 pg dose of APO may have primed pacing behavior. DA also contributes to pre­
reward motivational arousal [152]. Immediate dopaminergic action is an amplifying 
condition for pre-reward motivation [152]. Therefore, priming the animal with 120 pg 
of APO may have amplified pre-reward motivation which may have caused an increase 
in pacing behavior.
Experiment 2 examined the effects of increasing doses of APO on copulatory 
behavior in female mice, but the effects of the treatment on DA containing neurons was 
not measured. The following experiment (Exp 3) measured DA and metabolites in brain 
areas of mice treated with APO to better understand APO’s effects. The group treated 
with 120 pg of APO had significantly higher levels of DA in the Nacc and significantly 
lower levels of HVA/D A in the striatum and Nacc compared to controls. Nacc DA 
increases and HVA/DA ratio decreases indicate that APO induces increased DA release 
and that DA is not metabolized as rapidly as in controls (i.e. a decrease in turnover). The 
same dose significantly increased pacing behavior. Thus the change in concentrations is 
correlated with the increased pacing seen in the previous experiments and previous
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reports. This relationship suggests that in mice as in rats [2, 3,139] and hamsters [24] the 
mesolimbic DA system contributes to paced reproductive behaviors.
Treatment with 60 pg of APO induced significant increases of HVA in the VMN. 
The same dose also induced the lowest levels of receptivity. HVA is a metabolite of DA, 
indicating that there was increased in DA activity. This results agrees with several 
studies that demonstrate an inhibitory effect of DA in the VMN on lordosis in female rats 
[143,144], Decreased receptivity may be due to increased DA activity in the VMN.
This result is important because the VMN mediates reproductive behavior in female 
rodents [53, 54], Therefore the decreased receptivity displayed by this group may be due 
to the increased activity of DA in this area. These results further support the hypothesis 
that there are different neural mechanisms underlying pacing and receptive components 
of sexual behavior. The increase in DA in the VMN may underlie the receptive 
component of female mouse behavior, while DA in the Nacc, may be the underlying 
mechanism of pacing behavior.
Pacing is a copulatory behavior but also consists of locomotor behavior.
Numerous studies have demonstrated that APO has both excitatory and inhibitory effects 
on locomotor behavior [92, 93]. This information is relevant to this dissertation because 
pacing and receptive behavior heavily involves locomotor behavior. If locomotor 
behavior is compromised, copulatory behavior can be directly affected. Therefore it was 
important to examine the effects of the previously used doses (20 pg, 60 pg, and 120 pg) 
of APO on locomotion. An open field apparatus was used so that locomotion as well as 
exploratory behavior and anxiety was measured. APO increased locomotor behavior and 
anxiety, while decreasing exploratory behavior. At the 120 pg dose of APO, an increase
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in locomotion, anxiety and pacing behavior were observed. Thus changes in pacing 
behavior parallels increased locomotion. Increased anxiety may also contribute to 
pacing, if the APO treated subjects are more anxious they may be more likely to pace as 
they may want to escape from the male. In addition, at the 60 pg dose, a decrease in 
receptivity was seen and there was also a significant increase in anxiety. The increase in 
anxiety may contribute to the significant decrease in receptivity.
The previous experiments focused on the effects of APO on copulatory and 
locomotor behaviors. APO increased pacing behavior, anxiety and locomotor behavior in 
a dose dependent manner while decreasing receptive and exploratory behavior in a dose 
dependent manner. These results led to further investigation of how DA mediates pacing 
and receptive behavior by specifically using Dj and D2 receptor agonists. Di and D2 
receptors differentially effect copulatory behavior in rats [23, 130, 131]. Dose dependent 
increases were expected after treatment with Di agonists and dose dependent decreases 
were expected after treatment with D2  agonists [23, 130,131]. However neither agonist 
had an effect on pacing or receptive behavior. Di and D2 receptor activation effects on 
pre and postsynaptic DA receptors may explain the results.
Studies have shown that Dj receptor activation decreases presynaptic effects [96]. 
When presynaptic DA receptors are stimulated, DA synthesis is inhibited because activity 
of tyrosine hydroxylase is blocked, DA release from presynaptic membrane-enclosed 
storage vesicles is blocked and the firing rate o f DA neurons is attenuated [150, 151]. Dj 
receptor activation inhibiting presynaptic DA receptors may result in increased DA 
synthesis and release [4], Postsynaptic DA receptor activation increases DA transmission 
and Dj stimulation of postsynaptic DA receptor may further increase DA transmission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
I l l
Generally pacing and receptive behaviors are correlated with increased DA in the 
Nacc and striatum [2, 3,139]. Di agonists may have increased Nacc and striatum DA 
transmission in the female mice. If DA transmission increased because of treatment with 
Di agonists, less pacing behavior or receptive behavior may be needed for reward. This 
may explain why there were no changes in copulatory behavior in mice treated with the 
Di agonist.
Mice treated with the D2 agonist displayed no changes in copulatory behavior. 
Generally D2  binding and presynaptic D2 activity are necessary to activate an inhibitory 
effect, while increased D2 binding is required to activate an excitatory effect [100]. 
Expected decreases may not have been seen because low doses of quinpirole used may 
not have been enough to stimulate D2 binding and activate presynaptic receptors which 
may explain the lack of change in behavior. Therefore the lack of decrease in both 
pacing and receptive behavior may be due to the lack of sufficient binding.
In conclusion, female mice display both receptive and pacing behaviors. DA 
regulates these behaviors through action in the Nacc, striatum and the hypothalamus.
APO caused dose dependent increases in pacing and dose dependent decreases in 
receptivity. APO also caused dose dependent increases in DA levels in the Nacc and 
HVA in the VMN which correlated with the behavioral changes. Though Dj and D2 can 
influence pre and postsynaptic effects on copulatory behavior in opposite directions [23, 
130,131], there were no differences in either pacing or receptivity when female mice 
were treated with Di and D2 agonists.
Future controlled studies are needed to examine the effects of copulatory behavior 
on DA transmission as well as the effect of DA transmission on copulatory behavior.
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Further experiments measuring DA receptor binding after treatment with APO during 
sexual testing, particularly during pacing and receptive behaviors are needed to 
understand how DA receptors mediate these behaviors in female mice. Extracellular DA 
levels during pacing and receptivity behavior should also be measured in female mice as 
they have been done in female rats [2].
Though useful information was collected, there were shortfalls that may have 
affected results that warrant further discussion. Copulatory behavior in female mice was 
studied. However all experiments in this dissertation used female mice that were 
displaying low levels of receptivity. Mice need six weeks of hormone treatment and 
weekly testing before they show maximal receptive behavior [47]. Unlike female rats 
that will show maximal sexual behavior after being hormone primed and tested a small 
amount of times [12] mice need a longer period to become fully receptive [48]. The 
experiments for this dissertation were based on rat studies which is why female mice 
were tested after 2 weeks of hormone treatment and testing. Future experiments 
examining sexual behavior in female mice should allow ample time for hormone priming 
and weekly testing until maximum receptivity is achieved. If the experiments had 
allowed for increased hormone priming and weekly testing, it is expected that some of 
the results may have been altered.
Another potential confound was the potential activation of pre and postsynaptic 
DA receptors. Low doses of APO activate presynaptic DA receptors which cause a 
decrease of DA synthesis and release [4], Therefore at low doses, APO acts as an 
antagonist. High doses of APO activate postsynaptic DA receptors and acts as a DA 
agonist. Being aware at what dose a drug acts as an agonist versus an antagonist is
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crucial for maintaining the validity of the experiment. APO was administered at various 
doses and expected to act as an agonist. However, the lower doses may have been 
antagonistic. Drugs acting as antagonists when they are expected to act as agonists may 
compromise the data. In addition, any drug used during testing of pacing or receptive 
behavior should first be tested to establish if  the drug affects locomotor activity. If the 
drug does affect locomotion, this change can interfere with the desired behavior of 
interest.
Finally, even though the pacing apparatus used in these experiments successfully 
allowed for observation and measurement of pacing behavior, it could be improved. The 
pacing cubes allowed for the female to escape the male and protected her on all sides. 
However, if the pacing cubes could be darkened, they may be more effective. Darkened 
cubes would take advantage of mice’s preference to be in dark, hidden places [149]. 
Therefore the females would be less anxious and more comfortable entering the cubes 
and acclimate to them faster.
The information gathered from this dissertation can be broadened to clinical use. 
Currently clinical studies of human sexual behavior greatly depend on self reports of 
sexual desire, function and pleasure [153]. Studying the interaction between sexual 
behavior, neurotransmitter and endocrine regulation can be used to investigate sexual 
dysfunctions such as vaganismus (inability to relax vaginal walls for entry), dyspareunia 
(pain during intercourse), and infertility. Specifically, examining copulatory behavior 
using a female mouse pacing apparatus can provide further information. Information can 
be gathered to help investigate estrogen’s effects on sexual desire in relation to 
menopause or women who are diagnosed with hypoactive sexual desire. It can also
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increase our knowledge of the relationship between oral contraceptives that contain 
increased progesterone and subsequently have been reported to decrease sexual desire.
In addition many psychoactive medications that affect serotonin activity produce 
sexual side effects, particularly selective serotonin reuptake inhibitors (SSRIs) which act 
to increase serotonin levels and are associated with sexual side effects such as decreased 
libido [154]. Using a pacing paradigm with mice can help find remedies which reverse 
SSRIs induced sexual dysfunction. Additionally, antiparkisonian and antipsychotic 
medication have been reported to impair sexual function [155]. However little research 
has been done to examine how DA mediates female sexual dysfunction. A pacing 
paradigm developed using female mice may be able to provide more insight.
Illicit drug use has been demonstrated to enhance [156] or inhibit sexual function 
[156-159]. Cocaine enhances DA activity by blocking presynaptic autoreceptors and is 
commonly believed to enhance sexual pleasure [160]. However chronic cocaine use can 
impair sexual function [157, 158]. In addition, withdrawal from cocaine can produce a 
temporary reduction in sexual desire [159],
Finally the various components of female mice copulatory behavior can be used 
as an additional model to study the DA mesolimbic “reward” system. Currently study of 
this system is mainly confined to drug addiction [55, 56] and food seeking models [161 - 
163]. Copulatory behavior, particularly pacing behavior can be viewed as another 
motivated or rewarding behavior that can be manipulated to study the mediating effects 
of monoamines and metabolites within the mesolimbic DA system.
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